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Actinobacteria are Gram-positive bacteria and the prolific producers of bioactive 
molecules. In the course of drug discovery from actinobacterial sources, some samples 
were taken from different locations and habitats of Indonesia and isolation of 
Actinobacteria was conducted thereof. Totally 196 strains of Actinobacteria were 
isolated, and approximately half of them were characterized by 16S rRNA gene 
analysis. Around two-thirds of them were detected as Streptomyces. One of the 
Streptomyces strains, i.e., strain SHP 1-2 produced active extracts against some 
microbial pathogens. Analysis and isolation of compounds from its extract revealed 
that two novel molecules, which are indolactam derivatives, were found from it. 
Polyphasic taxonomy study of strain SHP 1-2 suggested that this strain is a novel 
species in the Streptomyces group. Another study from different strains suggested that 
strain MAE-11, isolated from mangrove area, was identified close to Kitasatopora and 
Streptomyces species and generated active extract against hepatitis C virus (HCV). 
The extract was known to contain bafilomycin D as the molecule that was responsible 
for the antiviral activity. Isolate 196526CR was detected as Amycolatopsis species and 
could produce an extract that showed activity against some tested microbes. The 
compound analysis and isolation from its extract indicated that nitrosoxacin C 
possesses property as an antimicrobial compound. Chemotaxonomy study of strain 
ASO4wet, which was previously isolated from deep-sea in the North Atlantic Ocean, 
was also conducted and the data supported that ASO4wet belongs to the genus 
Streptomyces. The strain is described as the novel species.     










Actinobakterien sind Gram-positive Bakterien und die ergiebigsten Produzenten 
bioaktiver Moleküle. Im Zuge der Wirkstoffforschung aus Actinobakterien wurden 
einige Proben an verschiedenen Orten und Lebensräumen Indonesiens entnommen 
und daraus Actinobakterien isoliert. Insgesamt wurden 196 Aktinobakterien-Stämme 
isoliert und etwa die Hälfte von ihnen wurde durch 16S-rRNA-Genanalyse 
charakterisiert. Etwa zwei Drittel von ihnen wurden als Streptomyces identifiziert. 
Einer der Streptomyces-Stämme, d. h. Stamm SHP 1-2, produzierte aktive Extrakte 
gegen einige pathogene Mikroorganismen. Nach Analyse und anschließender 
Isolierung der Inhaltsstoffe konnten zwei neue Substanzen, die zu der Indolactam-
Derivaten gehören, gefunden werden. Eine polyphasische Taxonomiestudie des 
Stammes SHP 1-2 legte nahe, dass dieser Stamm zu einer neuen Spezies in der Gattung 
Streptomyces-gehört. Eine vergleichende Studie mit verschiedenen Stämmen legte 
nahe, dass der Stamm MAE-11, der aus Mangrovengebieten isoliert wurde, nahe 
verwandt mit Kitasatopora- und Streptomyces-Arten ist und einen aktiven Extrakt 
gegen das Hepatitis C-Virus (HCV) produziert. Es zeigte sich, dass der Extrakt 
Bafilomycin D als die Substanz enthielt, die für die antivirale Aktivität verantwortlich 
war. Das Isolat 196526CR wurde als Amycolatopsis-Spezies identifiziert und bildet 
einen Extrakt, der eine Aktivität gegen einige Mikroorganismen zeigte. Die Analyse 
der Bestandteile und die Isolierung aus diesem Extrakt zeigten, dass Nitrosoxacin C 
für die antimikrobielle Eigenschafte verantwortlich ist. Eine chemotaxonomiche 
Studie des Stammes ASO4wet, der aus der Tiefsee im Nordatlantik isoliert worden 
war, wurde ebenfalls durchgeführt, und die Daten untermauerten, dass ASO4wet zur 
Gattung Streptomyces gehört. Der Stamm wird als neue Art beschrieben. 






1.1 Natural product and drug discovery 
Natural products are various chemical compounds produced by bacteria, fungi, plants, 
and animals. These include the primary metabolites such as DNA, RNA, and protein 
and the secondary metabolites such as isoprenoids, alkaloids, polyketides, and 
peptides, especially nonribosomal peptides1–4. However, the definition of natural 
product usually is used by many scientists to refer to the secondary metabolites 
produced by organisms1. Not like the primary metabolites, which are very important 
for the growth and reproduction, the secondary metabolites give other bioactivity 
benefits to the producing organisms. They could be used for defensive or attack 
mechanisms, competition with the other organisms, and interspecies communication. 
Therefore, it can be considered that the secondary metabolites are required for survival 
of the hosts in their environment5.  
More than one million of natural products have been isolated recently. They are 
essential and valuable agents in human life. People have used them for many 
applications such as in nutrition, medicine and agriculture. Many of them originate 
from plants (50-60%) such as alkaloids, flavonoids, terpenoids, and steroids and 
microbes produce only a small portion (about 5%). However, only 20-25% of these 
compounds possess biological activity and circa 10% of these active molecules are 
produced by microbes, especially from Actinobacteria which contribute around 45% 
followed by fungi (~38%)6–8 as shown in Figure 1. 
     
Figure 1. Distribution of natural products produced by organisms. Data are derived 
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Microbes have supplied compounds they produced that have helped people to 
overcome diseases for 70 years. These comprise antibiotics, antitumor drugs, 
immunosuppressants, enzyme inhibitors, and antiviral agents2. The history of drug 
discovery from microbial sources has been started since 1929 when Alexander 
Fleming published his work about the antimicrobial activity from the mould 
Penicillium notatum that killed Staphylococcus aureus9. Since then, many scientists 
have worked to find drugs from microbial sources. In 1942, Waksman and Tishler 
published their finding of actinomycin which was produced by Actinomyces 
antibioticus (the current name is Streptomyces antibioticus) that has antibacterial 
activity10.  
The “heroic” or “golden era” of antibiotics is between the 1940s-1950s when almost 
all valuable antibacterial drugs were found, such as tetracyclines, cephalosporins, 
aminoglycosides, and macrolides. It was suggested that in the period between the 
1950s-1960s, the major issues in chemotherapy had been resolved. Interestingly, 
antibiotics discovered in this era were predominantly produced by Streptomyces 
species. Streptomyces was reported to produce 70-80% of the all discovered 
antibiotics, which are mainly active as antibacterial and antifungal agents. However, 
there were some false classification of Steptomyces species, e.g., Streptomyces 
erythraeus, which was then amended to Saccharopolyspora erythraea.  In this period, 
also, the discovery of other bioactivities such as antitumor, antiviral, and enzyme 
inhibitor had just commenced8,11.    
In the 1970s-1990s, because of the cost of research had raised, the research had 
become laboriously. The novel compounds that were discovered in this period were 
primarily analogues of previously known metabolites. The area of research had 
become broad such as finding molecules for antitumor and agricultural antibiotics. In 
this period, problems of the emerging new pathogens and the growing of multi-
resistant strains had become essential issues to be resolved. In the same time, it was 
also reported that many novel compounds produced from “rare actinomycetes” had 
been isolated and elucidated. This “rare actinomycetes” include the genera from 
actinomycetes beside Streptomyces such as Micromonospora, Actinomadura, 





From the 1990s until nowadays, the reports of the novel isolated compounds have been 
dramatically increased; however, these mostly belong to non-antibiotic molecules, 
analogous, and minor metabolites. The amount of novel chemical types had decreased. 
It is also recognized that there was an innovation gap in the period between 1962 and 










Figure 2. Timeline of introduced antibiotics. Adapted from Fischbach and Walsh13. 
On the other hand, the problems of multi-resistant strains, emerging new pathogens 
and re-emerging pathogens are increasing recently. The issues should be resolved; 
therefore, novel strategies are needed for discovering novel drugs. Some novel 
approaches for drug discovery have been carried out in recent times. These include the 
biodiversity-based method, modifying cultivation conditions, and genome mining8,14.  
In the biodiversity based method, finding the novel species of bacteria is required in 
the effort of finding new antibiotics. There is a close relationship, based on the 
investigation during recent decades, between the discovering of new antibiotics and 
the description of novel bacteria species particularly within the Actinobacteria and 
gliding bacteria. It is suggested that the possibility of finding out novel compounds 
with unique structures are undoubtedly associated with the novel species. The method 
for isolation the novel species can be carried out by exploring the unexplored habitats 
such as desert, deep sea, and endosymbiotic environment. One of the underexplored 
countries, for Actinobacteria biodiversity, is Indonesia. Indonesia has an enormous 
territory encompassing 17,000 islands with diverse habitats and as one of the countries 


















having vast biodiversity in the world. Therefore, isolating Actinobacteria from 
Indonesian samples may increase the chance of either finding novel species or 
bioactive compounds. The other method which is still related to the biodiversity is by 
isolating and studying the bacteria which are not part of the taxa of eminent antibiotic 
producers14–16.     
Some previous investigations suggested that the secondary metabolite profile of a 
bacterial species is possibly changed by modifying the culture conditions. By using 
whole-genome sequencing, it is finally understood that most fungi and bacteria have 
the capacity to generate more compounds than they usually produce in the standard 
cultivation condition. Changing the cultivation condition may be carried out by 
altering some parameters such as the concentration of phosphate in the medium, media 
composition, aeration, culture container, and addition of some enzyme inhibitors, 
solvents, and heavy metals. The other method is by using the co-culture method either 
with live or dead cells. By conducting such modifications, the probability to enhance 
the number of compounds produced by one strain is postulated become high. This 
method is known as OSMAC (One Strain-Many Compounds). The technique is 
suggested to stimulate the expression of the silent (cryptic) metabolic pathways in the 
microbial strains that can improve the variety of compounds they generate. However, 
this method is a random technique that is difficult to establish general standards for all 
strains14,17–19.  
Genome mining is the method of retrieving information from genome sequences of 
species. This method can be conducted by detecting and analyzing the biosynthetic 
gene clusters of secondary metabolites and afterwards associating it to the 
corresponding chemical entities. Biosynthetic gene clusters are the main structures of 
the biosynthetic pathway of compounds at the genome level, which typically encode 
multidomain enzymes, such as polyketide synthases (PKS), nonribosomal peptide 
synthetases (NRPS), transporters, and some tailoring enzymes. The tailoring enzymes 
are some enzymes needed for a specific reaction such as halogenation, oxidation, 
glycosylation, and cyclisation. The determination of the biosynthetic gene cluster can 
be accomplished base on homology with notorious secondary metabolite gene 
clusters. This homology is obtained from the classification of previously recognized 
biosynthetic gene clusters based on the biosynthetic pathway, domain structure, 




compounds. The information derived from biosynthetic gene clusters can be employed 
to different methods such as guiding a more targeted drug discovery technique, peptide 
and glycogenomic approaches, and enabling the heterologous expression in the best 
expression host. However, it is still challenging to associate biosynthetic gene clusters 
to bioactivity14,15,20,21.  
1.2 Actinobacteria 
The phylum Actinobacteria is one of the most prominent taxonomic and essential 
groups among the primary lineages within the Gram-positive bacteria group. They are 
mostly characterized by having high guanine and cytosine (G+C) content in their 
genomes Actinobacteria comprises soil dwellers (Streptomyces spp.), plant symbionts 
(Leifsonia spp.), nitrogen-fixing commensals (Frankia), and gastrointestinal tract 
inhabitants (Bifidobacterium spp.). However, small numbers of Actinobacteria are 
recognized as pathogens such as Mycobacterium spp. (e.g. Mycobacterium 
tuberculosis that causes tuberculosis (TB) in humans), Nocardia spp., Tropheryma 
spp., Corynebacterium spp., and Propionibacterium spp. Most of Actinobacteria are 
aerobic, heterotrophic, and can be found in both terrestrial and aquatic ecosystems 
(including marine habitats)22,23. 
They generate about two-thirds of all clinically used antibiotics from natural products. 
Many Actinobacteria produce a mycelium like fungi. Because of this, they are 
considered as the transitional organisms between fungi and bacteria. The mycelium 
formed Actinobacteria reproduce by sporulation and are called actinomycetes, which 
originated from the Greek words for ray (aktis or aktin) and fungi (mukēs). The 
difference between actinomycetes and fungi is that the former have no nucleus, contain 
peptidoglycan in their cell wall, and are susceptible to antibacterial agents. Most of 
them are saprophytic and soil-dwelling bacteria that spend most of their life cycles as 
semi-dormant spores, particularly in the condition when their nutrients are scarce. 
They mainly grow better at a pH 6-9, with the most optimal growth around neutrality 
and are mostly mesophilic, which means that the temperature for their optimal growth 
is between 25-30°C22. 
The phylum Actinobacteria has six classes. These include Acidimicrobiia, 
Actinobacteria, Coriobacteriia, Nitriliruptoria, and Thermoleophilia. The class 
Actinobacteria encompasses 29 orders and 62 families, as shown in Table 1. From 62 




Actinobacteria (https://www.ncbi.nlm.nih.gov/taxonomy). Delineation of species in 
Actinobacteria is conducted by phenotypic and genotypic analysis. The primary 
phenotypic characteristics employed to delineate the taxonomy of Actinobacteria are 
based on the microscopic morphology and chemotaxonomy. For genotypic analysis, 
the taxonomic study of Actinobacteria can be carried out based on the 16S rRNA gene 
analysis, DNA-DNA hybridization, multilocus sequence analysis (MLSA), and 
genome sequencing22,24. 
Table 1. Current taxonomic outline for the phylum Actinobacteria. The data are based 
from taxonomy database in NCBI website (https://www.ncbi.nlm.nih.gov/taxonomy) 
Phylum  Class Order Family Genus 
Actinobacteria Acidimicrobiia, Acidimicrobiales 4 Families 10 genera 
Actinobacteria, Acidothermales    
Actinomycetales    
Actinopolysporales    
Bifidobacteriales    
Catenulisporales    
Corynebacteriales    
Cryptosporangiales    
Frankiales    
Geodermatophilales    
Glycomycetales    
Jiangellales    
Kineosporiales    
Micrococcales    
Micromonosporales    
Nakamurellales    
Propionibacteriales    
Pseudonocardiales    
Sporichthyales    
Streptomycetales    











































Coriobacteriia, Coriobacteriales    





Nitriliruptoria, Egibacterales    
Egicoccales    
Euzebyales    









Thermoleophilia Solirubrobacterales    










Bacteria of the genus Streptomyces can produce a secondary metabolite named 
geosmin. This compound does not have any antibiotic activity; however, it gives the 
soil its distinctive smell. They are perfectly adapted to survive in the soil where they 
grow by forming substrate mycelium that can help them to get nutrients. They secrete 
various enzymes that can digest insoluble organic polymers and numerous secondary 
metabolites that may be suggested not only as chemical weapons for killing other soil 
organisms but also as signalling molecules for modulating the metabolic process in 
target organisms. They also have antibiotic resistance genes to protect themselves 
from their own produced antibiotics. These resistance genes, however, can be 
transferred to other bacteria via horizontal gene transfer. The life cycle of 
Streptomyces starts with spore germination, forming vegetative hyphae, and continues 
to create substrate mycelium. The exponential growth of the vegetative hyphae is 
accomplished through a combination of tip extension and branching. The cell division 
during vegetative growth creates cross-walls that separate the hyphae into connected 
compartments. In response to unfavourable conditions such as nutritional deficiency 
and other stress signals, the vegetative mycelium differentiates to form reproductive 
aerial hyphae, which undergo cellular division to produce spores. Most of the 
antibiotics are formed in this differentiation moment; however, many industrial 
processes for secondary metabolite production from Streptomyces are accomplished 
with liquid cultures. Under these conditions, Streptomyces strains usually do not 
sporulate22,25,26. The morphology of Streptomyces species can be seen in Figure 3.  
Streptomyces strains can produce various antibiotics with different structures and 
functions such as inhibition of DNA replication and the synthesis of RNA, cell wall, 
and protein. Some examples of antibiotics produced by Streptomyces species are 
streptomycin from S. griceus, cephalosporin from S. clavuligerus, chloramphenicol 
from S. venezuelae, daptomycin from S. roseosporus, and novobiocin from S. niveus. 
Streptomycin and chloramphenicol are the inhibitors of bacterial protein synthesis. 
Streptomycin binds to the small 16S rRNA of the 30S ribosomal subunit, while 
chloramphenicol binds to 23S rRNA of the 50S ribosomal subunit. Cephalosporin was 
firstly isolated from fungus Acremonium chrysogenum and then it was known that 




cell wall, while daptomycin can break up the cell membrane. As for novobiocin, it has 
another mechanism of antibacterial activity by binding to DNA gyrase27,28. Some other 
antibiotics produced by Streptomyces species are shown in Table 2. 
 
Figure 3. Streptomyces sp. strain C196921 in agar medium 
 
Table 2. Some antibiotics produced by Streptomyces species 
Antibiotic Class of molecule Function Producer Reference 
Arylomycin Lipopeptides Inhibition of 





Capreomycin Peptides Inhibition of 
protein 
synthesis 
S. vinaceus  
S. capreolus 
31 
Cephalosporins β-Lactams Inhibition of 
cell wall 
synthesis 
S. clavuligerus 32,33 
Chloramphenicol Chloramphenicols Inhibition of 
protein 
synthesis 
S. venezuelae 34,35 





S. garyphalus 36,37 
Daptomycin  Lipopeptides Destruction of 
the membrane 
potential 




Fosfomycin Fosfomycin Inhibition of 
cell wall 
synthesis 
S. fradiae 39 
Kanamycin Aminoglycosides Inhibition of 
protein 
synthesis 
S. kanamyceticus 40 
Lincomycin Lincosamides Inhibition of 
protein 
synthesis 
S. lincolnensis 41 
Neomycin Aminoglycosides Inhibition of 
protein 
synthesis 
S. fradiae 42,43 
Novobiocin  Aminocoumarins Inhibition of 
DNA gyrase 
S. niveus 44,45 
Oleandomycin Macrolides Inhibition of 
protein 
synthesis 
S. antibioticus 46,47 
Platensimycin Platensimycin Inhibition of 
fatty acid 
production 
S. platensis 48 






Ribostamycin Aminoglycosides Inhibition of 
protein 
synthesis 
S. ribosidificus 50 
Spiramycin Macrolides Inhibition of 
protein 
synthesis 
S. ambofaciens 51 
Streptomycin Aminoglycosides Inhibition of 
protein 
synthesis 
S. griseus 52 
Tetracycline Tetracyclines Inhibition of 
protein 
synthesis 
S. aureofaciens 53,54 
Viomycin Peptides Inhibition of 
protein 
synthesis 
S. vinaceus,  
S. capreolus 
31 
Virginiamycin Streptogramins Inhibition of 
protein 
synthesis 
S. virginiae 55 
 
1.2.2 Non-Streptomyces Actinobacteria 
In contrast to the member of the genus Streptomyces that produce around 74% of 











only about 26% of the antibiotics of their origin. This non-Streptomyces 
Actinobacteria are called rare actinomycetes, which comprise more than 200 genera 
e.g., Actinomadura, Actinoplanes, Amycolatopsis, Actinokineospora, 
Acrocarpospora, Actinosynnema, Catenuloplanes, Cryptosporangium, 
Dactylosporangium, Kibdelosporangium, Kineosporia, Kutzneria, Microbiospora, 
Micromonospora, Microtetraspora, Nocardia, Nonomuraea, Planomonospora, 
Planobispora, Pseudonocardia, Saccharomonospora, Saccharopolyspora, 
Saccharothrix, Streptosporangium, Streptoverticillium, Spirilliplanes, 
Thermomonospora, Thermobifida, and Virgosporangium8,56. The morphology of 
some non-Streptomyces can be seen in Figure 4.  
Rare actinomycetes are frequently referred to the strains of Actinobacteria whose 
isolation rate is considerably less than that of the Streptomyces strains isolated by 
classical approaches. In comparison with Streptomyces, they have not been 
extensively investigated in previous years and might become new sources of novel 
secondary metabolites. These bacteria are extensively distributed both in terrestrial 
and aquatic ecosystems. Their distribution is influenced by some environmental 
elements such as soil type, pH, humus content, and the characteristics of the humic 
acid content of the soil. While non-Streptomyces Actinobacteria may increase the 
probability of discovering novel compounds, their genetics and physiology are not 








Figure 4. Some non-Streptomyces strains in agar medium 
The prolific group of non-Streptomyces Actinobacteria is represented by Actinoplanes 




spores that are mobile and have chemotactic movement. These groups of bacteria 
produce more than 120 antibiotics such as teicoplanin, ramoplanin, purpuromycin, 
lipiarmycin, and actagardine. Another group of non-Streptomyces Actinobacteria 
isolated on an enormous scale over the last few years belong to the genus 
Micromonospora. This genus is regarded as the second biggest group of culturable 
Actinobacteria in soil and can be isolated by using selection medium containing 
antibiotics such as gentamicin and novobiocin or with the pre-treatment by using toxic 
agents such as phenol and chlorhexidine gluconate solutions because their spores are 
resistant to these chemicals. Micromonospora strains produce some important 
antibiotics such as gentamicin, sisomicin, fortimicin, mycinamicins, rosamicins, and 
everninomycin57. Some other antibiotics produced by non-Streptomyces species are 
listed in Table 3. 
1.3 Polyphasic taxonomy of the class Actinobacteria 
Taxonomy, which is the synonym of systematics or biosystematics, is essential in 
studying organisms. It comprises three main parts, i.e., classification, nomenclature, 
and identification. Classification can be carried out by organizing organisms based on 
similarity into taxonomic groups. The term nomenclature includes giving the label of 
the units determined in classification. Identification means the process of deciding 
whether an organism is a member of one of the units determined in classification and 
labelled in nomenclature. Taxonomic information helps scientists to figure out the 
biodiversity and correlation among organisms from distinct ecological systems. 
Taxonomy in prokaryotes has an indispensable function in supporting the accurate 
identification of microbial strains from difference varieties58,59.    
Table 3. Some antibiotics produced by non-Streptomyces species  
Antibiotic Class of molecule Function Producer Refe-
rence 










































































Nonomuria rubra 76,77 
































































Bacterial taxonomy commenced in the late 19th century when the classification was 
only based on simple phenotypic markers such as morphology, growth requirements 
or pathogenicity. Subsequently, the other properties, i.e., physiological and 
biochemical, were added for this purpose. In the period of 1960s-1980s, 
chemotaxonomy, numerical taxonomy and DNA–DNA hybridization techniques were 
applied in studying taxonomy. Later, in the 1980s, the emergence of DNA 
amplification and sequencing techniques, especially of the 16S rRNA gene, created 
significant progress in bacterial classification. Since the mid-1990s, whole-genome 
sequencing cretaed an innovation by providing an approach to obtain the complete 
genetic information of a single strain59. 
In order to establish reliable taxonomy of bacteria, integration of phenotypic, 
genotypic, and phylogenetic information of the strains is needed, and this is called 
polyphasic taxonomy. Phenotypic information is derived from main physical 
characteristics such as morphology, staining properties, ultrastructure, 
chemotaxonomic markers, physiological properties, biochemical features, protein 
composition, and pathogenesis. Meanwhile, genotypic data are obtained from the 
nucleic acids (DNA and RNA) in the cell such as analysis of DNA–DNA hybridization 
(DDH), DNA G+C content and 16S rRNA gene sequencing58,59,94. Some other 
methods recently used for genomic taxonomy study include ribotyping and whole-
genome analysis95,96. Phylogeny depicts biological entities that are connected through 
common descent. It can be species, genus or higher-level taxonomic groups. A 
phylogenetic tree is used for understanding not only the relationships among taxa (or 
sequences) but also their hypothetical related predecessors. Currently, most 





As mentioned above, the class of Actinobacteria is an essential group in both health 
and economy that consists of 29 orders and 62 families. In the effort of discovering 
drugs from Actinobacteria sources, polyphasic taxonomy is needed either for 
establishing reliable identification of antibiotics producing strains or as a dereplication 
tool to avoid redundancy in the selection of Actinobacteria species97. Microscopic 
morphology and chemotaxonomy are the primary characteristics employed to 
delineate the taxonomy of Actinobacteria at the genus and species levels. However, 
with the recent development in molecular analysis, some species that were 
inadequately positioned in particular taxonomic groups have recently been reclassified 
using molecular analyses22. 
1.3.1 Phenotypic analysis 
Various morphologies can be found in Actinobacteria, which include coccoid 
(Micrococcus), rod-coccoid (Arthrobacter), irregular rods (Propionibacterium), 
fragmenting hyphal forms (Nocardia), and permanent and highly differentiated 
branched mycelia (Streptomyces, Kitasatopora and Frankia). The members of 
genus Rhodococcus form elongated filaments without producing a real mycelium. The 
members of genus Corynebacterium produce no mycelia. There is also a group that 
can break up its hyphae into flagellated motile elements (Oerskovia). Some members 
of Mycobacterium and Rhodococcus mostly do not form aerial hyphae22,98,99. 
Spore is one of the important markers in the taxonomy of Actinobacteria, although 
some Actinobacteria produce no spores, e.g., the members of Bifidobacterium, 
Micrococcus, and Propionibacterium. Spores may be produced on the substrate only 
(Micromonospora) or both on the substrate and the aerial mycelium (Streptomyces) 
either as single cells or in chains with several of length. In some groups, spores may 
be sheltered in specialized vesicles called sporangia (Actinoplanes, Planomonospora, 
Planobispora, Dactylosporangium, and Streptosporangium) and equipped with 
flagella for the motility of spores (Actinoplanes and Actinosynnema)22,100,101. 
Some Actinobacteria can produce various pigments, including melanin based on the 
medium that is used and the age of the culture. These may be red, yellow, orange, 
pink, brown, greenish-brown, blue, or black. Melanins are polymers with various 
structures that usually appear black or brown and are derived from oxidative 
polymerization of phenolic and indolic molecules. They are not necessary for the 




other organisms. They can be used in taxonomic studies and have a similar character 
to soil humic substances22. Investigation of pigments including melanin produced by 
Actinobacteria and their features of the morphology such as substrate mycelia, aerial 
mycelia, and spores can be conducted by utilizing International Streptomyces Project 
(ISP) medium102. The observation of spores formed by Actinobacteria is conducted 
employing a scanning electron microscope (SEM)103. 
As mentioned above, physiological and biochemical properties are parts of phenotypic 
criteria in the taxonomy study. Physiological data useful for Actinobacteria 
classification determinations include growth temperature, pH value, salt tolerance, 
growth on sole carbon sources, antibiotic resistance and oxygen requirement whereas 
biochemical features of interest are carried out by enzymatic activity test100,102,104–107.  
In the classification of Actinobacteria, the analysis of chemical components in the cell 
such as the analysis of cell-wall amino acids, lipids, proteins, menaquinones, muramic 
acid types, and sugars, is required22. Some genera contain 2, 6-diaminopimelic acid 
(DAP) in their cell-wall structure, which has isomers, i.e., LL-DAP and meso-
DAP. Streptomyces, Sporichthya, and Intrasporangium are the example of genera that 
have only LL-DAP. For meso-DAP, it can be found in the members 
of Mycobacterium, Nocardia, and Pseudonocardia. Hydroxy-diaminopimelic acid 
(OH-DAP), which is the derivative of DAP, is detected in Micromonospora strains. 
For whole-cell sugar patterns, Streptomyces species have no characteristic sugar 
pattern. Mycobacterium, Nocardia, and Pseudonocardia species have galactose and 
arabinose as their whole sugar pattern. Microbispora and Streptosorangium strains 
contain madurose, whereas the members of Actinoplanes, Dactylosporangium, and 
Micromonospora, possess xylose and arabinose108. 
Lipids, such as fatty acids, phospholipids, and menaquinones, have been used for 
chemotaxonomy of Actinobacteria. Fatty acids iso or anteiso C15:0, C15:0, or C17:0 
have been found as the predominant fatty acid in Rothia, Actinoplanes, Nocardiopsis, 
Amycolatopsis, and Streptomyces species106,109–112. Diphosphatidyl glycerol, 
phosphatidyl inositol mannosides and phosphatidyl inositol are mostly found in 
Actinobacteria species. Many Actinobacteria possess phosphatidyl ethanolamine 
except the members of Actinomadura, Corynebacterium, Microtetraspora, and 
Nocardioides. Phosphatidylcholine can be found in Actinomadura, Nocardia and 




contain menaquinone MK-8(H2) as the predominant menaquinone. MK-8(H4) is the 
primary menaquinone system in Nocardia members. Many Mycobacterium strains 
possess menaquinone MK-9(H2) as the primary menaquinone system. The 
menaquinone compounds in some Streptomyces are dominated with MK-9(H6), 
whereas in Actinomyces species, MK-10(H4) is the main menaquinone they have114.   
Some taxonomy studies in Actinobacteria were reported analyzing ribosomal protein 
using matrix-assisted laser-desorption/ionization time-of-flight spectrometry 
(MALDI-TOF MS)109,115,116. Ribosomal proteins have also been used for taxonomy 
study of bacteria since their peaks in MALDI-TOF MS are dominant, they are rather 
conservative molecules in the context of evolution, and their spectra are also specific 
of a particular strain and undergo only a little change with different culture 
conditions117.  
1.3.2 Genomic and phylogenetic analysis 
The genomic DNA G+C content is the ratio of guanine and cytosine within the total 
number of nucleotides in the genome. It is one of the taxonomic markers and can be 
employed for discriminating phenotypically similar microorganisms. It is also the 
primary characteristic of cellular DNA and is related with the amino acid composition 
of proteins, codon usage in mRNA, auxotrophy for specific bases, and other features 
of overall biological importance118,119. Class of Actinobacteria is encompassed mostly 
of Gram-positive bacteria with a high G+C content (>55 mol% in genomic DNA). 
Some members of Corynebacterium, however, have G+C content lower than 55% and 
even Gardnerella strains have G+C content which is less than 45%23,120.  
Ribosomal RNA has been used in the taxonomic study due to its availability in all self-
replicating systems, ease of isolation, and its sequence changes very slowly. 16S 
ribosomal RNA (16S rRNA) is one of the ribosomal RNAs in bacteria. 16S rRNA 
gene is used as the backbone for the classification of bacteria because it is ubiquitous, 
functionally stable, highly conserved and poorly subject to horizontal gene transfer 
(HGT). In the recent decade, comparative analysis of the 16S rRNA sequence, which 
has a size around 1,500 nucleotides, has been employed to study prokaryote 
phylogeny. In the 16S rRNA gene sequence analysis, the cut-off of identity values for 
determining novel genus is 95%, whereas it is 98.7% for novel species (previously it 
was 97%), when the 16S rRNA gene sequence of the tested bacterial strains are 




names59,121–123. In the case of Streptomyces species, previous studies found that there 
are some novel Streptomyces species, which have the similarity value of 16S rRNA 
gene sequence comparison 99.1-99.9%124–128.  
Ribotyping is a genetic fingerprinting method, which uses digested genomic DNA, 
separating it by gel electrophoresis, and hybridizing it with ribosomal DNA (rDNA) 
probe by Southern blotting technique. The restriction enzymes that are used can 
be EcoRI, PstI, PvuII, BamHI, ClaI and HindIII. The complete ribosomal operon 
from Escherichia coli is employed as the rDNA probe. The resulted pattern is a genetic 
fingerprint, which is useful to discriminate bacterial strains. Many bacterial species 
can be delineated with Ribotyping method, including Actinobacteria95,129.     
DNA–DNA hybridization is a commonly used technique to evaluate the genetic 
relationship between bacterial strains and is still known as the ‘gold standard’ principle 
for species delineation of prokaryotes. The tested bacterial strains are indicated as 
distinct species when their DDH values are ≤ 70%. DDH, however, has some 
shortcomings such as the cut-off values are not pertinent to all prokaryote genera, 
determining DDH values needs special facilities therefore the method is not available 
in many laboratories, and it is a laborious and expensive method that has shortage of 
reproducibility and is challenging to create a comparative reference database 
progressively from DDH data59.  
Multi-locus sequence analysis has been used for delineation some bacterial species in 
several genera, including members of Actinobacteria such as Mycobacterium, 
Streptomyces and Kitasatospora. By using the concatenation of partial gene sequences 
from five house-keeping genes, the closely related species of Streptomyces can be 
discriminated. These five house-keeping genes are atpD (ATP synthase F1, beta 
subunit), gyrB (DNA gyrase B subunit), recA (recombinase A), rpoB (RNA 
polymerase, beta subunit) and trpB (tryptophan synthase, beta subunit). This method 
is reproducible, can allow creating cumulative databases, and is comparable to DDH. 
The five-gene MLSA distance of 0.007 corresponds to a DDH value of 70%, which 
means that this value could be employed as the species cut-off for the whole 
Streptomyces genus. The sequences derived from the concatenated genes can also be 




Whole-genome data has also been used in bacterial taxonomy (including 
Actinobacteria), i.e., by aligning and comparing whole-genome sequences between 
two genome sequences from the closely related strains. The term overall genome 
relatedness index (OGRI) is coined to represent any measurements showing how 
identical two tested genome sequences are. The most commonly used algorithm for 
taxonomic investigations is average nucleotide identity (ANI). When comparing to 
DDH, 95-96% ANI value is equivalent to 70% DDH. It means ANI value can be 
employed to delineate novel species in bacteria96,132,133.  
1.4 Dereplication and isolation of natural products from Actinobacteria 
Discovering of bioactive molecules from Actinobacteria sources nevertheless requires 
substantial investments in technical equipment, time and human resources. Rapid 
identification of known substances, which is called dereplication, is one of the 
important strategies to focus the efforts on the finding of novel bioactive compounds. 
The term of dereplication nowadays, however, is a not so univocal and has developed 
in the past few years in different ways. There are many dereplication methods 
developed to enhance the success of natural product discovering programs134,135. 
Dereplication approach includes some methods, e.g., biological screening processes, 
LC-MS (liquid chromatography-mass spectrometry) techniques with the combination 
of MS libraries and databases, NMR (nuclear magnetic resonance) spectroscopy, and 
HTS (high throughput screening) technology. Taxonomic identification using 16S 
rRNA gene sequence has been used since the early of the 2000s as a dereplication tool. 
Bioactivity-guided assays with combination LC-MS have also been employed for 
dereplication approach97.  
Hubert et al.135 reviewed dereplication strategies in natural product research. They 
classified dereplication approaches into five categories, i.e., DEREP1, DEREP2, 
DEREP3, DEREP4, and DEREP5. Identification of the major compounds in a single 
extract is the activity in DEREP1. Systematically biological assay is included in 
DEREP2 (acceleration of activity-guided fractionation). DEREP3 is chemical 
profiling of crude extract collections. Chemical profiling of target compounds is 
conducted in DEREP4. The last, DEREP5 is the dereplication with taxonomic 
identification of microbial strains. Dereplication of natural products from 
Actinobacteria sources, therefore, may be conducted by using 16S rDNA analysis and 




Isolation of natural products from Actinobacteria may be carried out following the 
bioassay-guided isolation strategies that connect information on the chemical profiles 
of extracts and the active fractions. Extraction procedures employ organic solvents of 
different polarity, water and the mixtures of them or using solid-phase extraction 
(SPE) method136. Bioactivity assays can be done with antibacterial, antifungal, 
anticancer, or antiviral activity, e.g., antihepatitis virus, which is described briefly 
below. The antimicrobial test may be conducted either by using the zone inhibition 
test137 or serial dilution test with 96-well plate138. The further isolation process needs 
preparative thin layer chromatography (TLC) or column chromatographic methods. 
Finally, for the structure elucidation of the isolated compound, high resolution mass 
spectrometry (HR-MS) and NMR spectroscopy is employed136,139. HR-MS can 
provide accurate mass measurements that is needed for determination of chemical 
formula resulting high confidence in the structural elucidation139. As for NMR, it is 
used for determining the molecular structure of the compound140.  
1.5 Hepatitis  
Hepatitis is a disease identified by inflammation of the liver tissue and is caused 
mostly by viruses. There are five types of hepatitis viruses, i.e., type A, B, C, D, and 
E. Hepatitis A and E are usually caused by consuming contaminated food or water, 
while hepatitis B happens frequently through contact with infected bodily fluids like 
blood or semen. Hepatitis C virus is a blood-borne virus that is mostly transmitted by 
the usage of sharing needles from person to person. As for hepatitis D virus, it is spread 
with the infectious blood and the disease occurs only among the patients who have 
been infected by hepatitis B virus. Hepatitis B, C, and D plague more than half a billion 
people throughout the world and cause more than a million deaths annually141. 
Hepatitis A virus is a nonenveloped RNA with 7.5-kb genome size and belongs to the 
genus Heparnavirus of the Picornaviridae family142. Hepatitis B virus is a DNA virus 
and a member of the genus Orthohepadnavirus in the Hepadnavidae family143. 
Hepatitis C virus (HCV) is a member of the genus Hepacivirus in the 
family Flaviviridae. It is a positive single-stranded RNA virus with circa 9.6 kb size. 
It mainly propagated in the hepatocyte cytoplasm and mostly causes acute or chronic 
hepatitis C (CHC)144. Hepatitis D virus is an RNA virus and belongs to Deltavirus 
genus in the Deltaviridae family. It is a satellite virus of HBV because its incapability 




stranded and a positive RNA virus. It belongs to the Orthohepevirus genus in the 
Hepeviridae family. Its genome size is 7.2 kb and it is the primary cause of global 
enterically transmitted hepatitis146. 
1.6 Previous work 
In the course of Actinobacteria investigation from the neglected habitat sources, strain 
ASO4wet was isolated from the sponge in a deep sea. In December 2014, the Team of 
Prof. Dr. Peter Schupp (University of Oldenburg) took samples from marine sediment 
from 1092 m depth in the North Atlantic Ocean during an expedition with a new 
marine research vessel called Sonne. Study of 16S rRNA gene sequences revealed that 
strain ASO4wet is a member of the genus Streptomyces and exhibited the closest 
similarities to S. karpasiensis (98,94%), S. glycovorans (98%) and S. abyssalis (98%).  
DNA-DNA hybridization (DDH) analyses between strain ASO4wet and its closest 
related type strains indicated that strain ASO4wet is a distinct species from its 
compared closest species. Some studies have been conducted regarding to the novel 
description of the novel species for strain ASO4wet, including morphology and 
biochemical comparison, DDH, ribotyping, and MALDI-TOF analysis. From these 
studies, it is known that strain ASO4wet is different based on the morphologic, 
biochemical, and genomic characteristic from its close neighbours. However, 
chemotaxonomy study such as fatty acid, phospholipid, cell-wall amino acid, and 
whole-cell sugar analysis, of isolate ASO4wet has not yet been conducted and 
therefore, it needs to be carried out in order to fulfil the requirement of polyphasic 
taxonomy of strain ASO4wet147. 
1.7 Aim of study 
The objectives of the research are: 
1) Isolation of  Actinobacteria from Indonesia 
2) Cultivation and induction of secondary metabolite production (by using 
different media) 
3) Extraction and screening of bioactivity, including antimicrobial and antiviral 
activity 
4) Analysis, isolation and structure elucidation of metabolites produced by 
isolated Actinobacteria 
5) Taxonomic study of selected Actinobacteria strains including strain 
ASO4wet  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Media 
All of the media were sterilized for 20 min at 121°C.  






ISP medium (International 
Streptomyces Project) 
 
   
ISP2/ Yeast malt agar 
Maintenance and taxonomy 
Malt extract                        
Yeast extract                        
Glucose                                
Agar                                  







ISP3/ Oat meal agar 
Maintenance and taxonomy 
Oatmeal (Quaker white oats) 
Agar  
Deionized Water 






Trace salt solution ISP3 FeSO4 x 7H2O  
MnCl2 x 4H2O  
ZnSO4 x 7H2O  







Maintenance and taxonomy  
Soluble starch   
(NH4)2SO4  
K2HPO4  





















Trace salt solution  
Agar  








Trace salt solution ISP5 1,0 g FeSO4 x 7 H2O 
1,0 g MnCl2 x 4 H2O 
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Deionized water  100 ml 
ISP6 / Peptone Iron Agar 
Production of melanoid 
pigment 
Peptone 
Proteose Peptone  
Ferric ammonium citrate 
Sodium glycerophosphate 
Sodium thiosulfate-5-hydrate  
Yeast extract  
Agar  










ISP7/ Oat meal agar 







FeSO4 x 7 H2O  
Trace Salt solution (5343) 
Agar  















Glucose    
Yeast extract  
Malt extract  
CaCO3  
Agar  








GYM + ASW 
(Artificial Sea Water) 
GYM medium 
















MgSO4 x 7 H2O  
Trace element solution 2 (5341)  
Agar  















Basal medium for 
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Trace element solution 3 (5342) 




Trace element solution 2  
 
CuSO4 x 5 H2O   
CaCl2 x 2 H2O  
FeSO4 x 7 H2O  
ZnSO4 x 7 H2O  
MnSO4 x 7 H2O  









Trace element solution 3 
  
CuSO4 x 5 H2O  
FeSO4 x 7 H2O  
ZnSO4 x 7 H2O  









Trace element solution 4 
 
FeSO4 x 7 H2O  
ZnSO4 x 7 H2O  
MnCl2 x 4 H2O  









Casein peptone   
Yeast extract  
Agar  












Meat extract  
Yeast extract    
Tryptone soy broth  
NaCl  
K2HPO4  
MgSO4 x 7 H2O  
FeSO4 x 7 H2O  
Agar  

















Soluble starch   
Casein (Pepton Typ M)  
K2HPO4 
MgSO4 x 7 H2O 
Agar  
Deionized water  
10.0 g/l 




1000   
7.3 
 




Sterilized 5336 medium 
Cyclohexamide solution (50 mg/ml 
in methanol) 
Nalidixic acid solution (25 mg/ml 
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Medium 5254  
Metabolite production  
Glucose  
Soymeal  
Corn steep liquor  
CaCO3  
NaCl  










Starch (soluble)  
Yeast extract  
Glucose  
Glycerol  
Corn steep liquor  
Peptone (Marcor S)  
NaCl  
CaCO3  














Yeast extract  
Glucose  
Glycerol  
Corn steep liquor  













5254 + ASW 
(Artificial Sea Water) 
5254 medium 




5294 + ASW 
(Artificial Sea Water) 
5294 medium 




SYP medium  
 
Starch (soluble)  
Yeast extract  












Carl Roth GmbH + Co.KG, 
Germany 
  









Trypticase soy broth  Becton, Dickinson and Company, 
France  
  
Tryptone soy broth  Oxoid   
 




Table 5. List of chemicals used in this study. 
Chemical Manufacturer 
1 kb DNA ladder    BioLabs 
Acetic acid Carl Roth 
Acetone J.T. Baker 
Acetonitrile J.T. Baker 
Agarose Gibco BRL 
Ammonium acetate Carl Roth 
Ammonium iron(III)citrate ((NH4)5Fe(C6H4O7)2) Carl Roth 
Ammonium Sulfate (NH4)2SO4 Merck 
Aniline phthalate spray solution for TLC Carl Roth 
Anisaldehyde solution spray reagent Sigma-Aldrich 
Arabinose Merck 
Bacto Agar® Becton Dickinson 
Calcium carbonate (CaCO3) Panreac Appli Chem 
Casein (Pepton Typ M) Marcor 
Cellulose Serva, Heidelberg 
Copper(II) sulfate (CuSO4 x 5 H2O) Merck 
Corn steep liquor Schering 
Dimethylsulfoxid (DMSO) Carl Roth 
Dulbecco´s modified Eagle´s medium (DMEM) Bio Whittaker, Walkersville, MD 
Cyclohexamide Serva 
Ethanol J.T. Baker 
Ethyl acetate J.T. Baker 
Ethylenediaminetetraacetic acid (EDTA) Honeywell 
Ferric ammonium citrate Merck 
Fetal bovine serum (FBS) FBS, JRH Bioscience, Lenexa, KS 
Formic acid Sigma- Aldrich 
Fructose Carl Roth 
Glucose Carl Roth 




Hydrochloric acid (HCL) Carl Roth 
Inositol (Ino) Merck 
Iron(II) sulfate (FeSO4 x 7 H2O) Honeywell 
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Iron(III) chloride (FeCl3 x 6H2O) Merck 
Iron(III) citrate (FeC6H6O7 x H2O) Merck 
Iron(III) ethylenediaminetetraacetic acid (Fe 
EDTA) 
Fluka 
Jump Start Taq Ready Mix   Sigma- Aldrich 
K2HPO4 Merck 
KH2PO4 Carl Roth 
L-Arginine  Panreac Appli Chem 
L-Asparagine  Panreac Appli Chem 
L-Glutamic acid   Merck 
L-Isoleucine Fluka 
L-Methionine  Panreac Appli Chem 
L-Tyrosine Merck 
Malt Extract Carl Roth 
Meat Extract Carl Roth 
Molybdatophosphoric acid spray solution for TLC Merck 
Molybdenum blue spray reagent Sigma 
MgSO4 x 7H2O Carl Roth 
MnCl2 x 4H2O Merck 
NaCl Carl Roth 
Nalidixic acid Carl Roth 
α-Naphtol 
α-Naphtol spray reagent composition: 
15% α-naphtol in ethanol (10.5 ml)  
Concentrated H2SO4 (6.2 ml) 
Ethanol (40.5 ml) 
Deionized water (4 ml) 
Merck 
Ninhydrin spray reagent Sigma 
Peptone Becton Dickinson 
Peptone S Marcor 
Phytone peptone Carl Roth 
Potassium chloride (KCl)   Sigma- Aldrich 
Proteose Peptone Becton Dickinson 
Reef salt “Coral Ocean” ATI, Hamm 
Sodium glycerophosphate Fluka  
Sodium thiosulfate-5-hydrate Merck 
Soluble starch  Carl Roth 
Sucrose Merck 
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Sulfuric acid (H2SO4) Merck 
Water (nuclease free) Carl Roth 
Yeast extract                        Carl Roth 
ZnSO4 x 7H2O Merck 
 
 
2.1.3 Source of samples 
Table 6. List of samples collected from Indonesia for Actinobacteria isolation. 
Sample code Location of source Type of sample 
1808 Malang, East Java Soil 
1899 (FK1) Forest low altitude, Kendari, Southeast 
Sulawesi 
Soil 
1900 (FK2) Forest low altitude, Kendari, Southeast 
Sulawesi 
Soil 
1901 (FK3) Forest low altitude, Kendari, Southeast 
Sulawesi 
Soil 
1902 (FK4) Forest low altitude, Kendari, Southeast 
Sulawesi  
Soil 
1903 (MK5)  Mangrove, Kendari, Southeast Sulawesi  Soil 
1904 (MK6) Mangrove, Kendari, Southeast Sulawesi  Soil 
1905 (MK7) Mangrove, Kendari, Southeast Sulawesi  Soil 
1906 (MK8) Mangrove, Kendari, Southeast Sulawesi  Soil 
1907 (GC9) Cimahi, West Java Soil 
1929 Beach, Bali Sand 
1930 Beach, Bali  Dead barnacle 
1931 Beach, Bali  Algae red 
1932 Beach, Bali  Sand from reef 
1933 Beach, Bali  Sand 
1934 Beach, Bali  Sand 
1935 Beach, Bali  Sand 
1936 Beach, Bali  Green algae  
1937 Beach, Bali  Brown algae  
1938 Beach, Bali  Sand from reef 
1939 Beach, Bali  Sand from reef 
1940 Beach, Bali  Grass 
1941 Beach, Bali  Sand from reef 
1942 Beach, Bali  Sand 
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1943 Beach, Bali  Red stone from reef 
1944 Beach, Bali  Algae 
1945 Cultural Park, Bali Sand 
1946 Cultural Park, Bali Sand 
1947 Cultural Park, Bali Sand 
1948 Cultural Park, Bali Sand 
1949 Cultural Park, Bali Soil 
1950 Cultural Park, Bali Soil 
1951 Cultural Park, Bali Soil 
1952 Cultural Park, Bali Soil 
1953 Cultural Park, Bali Soil 
1955 Lava beach, Bali  Black sand 
1956 Lava beach, Bali  Black sand 
1957 Lava beach, Bali  Black sand 
1958 Lava beach, Bali  Black sand 
1959 Lava beach, Bali  Green algae 
1960 Lava beach, Bali  Black sand 
1961 Lava beach, Bali  Dead wood 
1962 Lava beach, Bali  Algae 
1963 Beach, Bali Sand 
1964 Botanical Garden, Bali  Soil with plant residue 
1965 Botanical Garden, Bali Soil with plant residue 
1966 Botanical Garden, Bali  Soil with plant residue 
1967 Botanical Garden, Bali  Soil with plant residue 
1968 Botanical Garden, Bali  Soil with plant residue 
1969 Botanical Garden, Bali  Soil with plant residue 
1970 Botanical Garden, Bali  Bark 
1971 Botanical Garden, Bali  Termite soil 
1972 Botanical Garden, Bali  Lichen grey 
1973 Botanical Garden, Bali  Fern residues 
1974 Botanical Garden, Bali  Swpr 
1975 Botanical Garden, Bali  Soil with moss 
1976 Ecology Park, Bogor, West Java  Dry grass 
1977 Ecology Park, Bogor, West Java  Bark 
1978 Ecology Park, Bogor, West Java  Soil 
1979 Ecology Park, Bogor, West Java  Dead wood 
1980 Ecology Park, Bogor, West Java  Dry leaves 
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1981 Botanical Garden, Bogor, West Java Exuvia Cicada? 
1982 Botanical Garden, Bogor, West Java Soil 
1983 Botanical Garden, Bogor, West Java Termite soil 
1984 Botanical Garden, Bogor, West Java Soil 
1985 Botanical Garden, Bogor, West Java Hypoxylon? 
1986 Botanical Garden, Bogor, West Java Bark 
1987 Botanical Garden, Bogor, West Java, Hypoxylon? 
1988 Botanical Garden, Bogor, West Java Bark dimocarpus 
1989 Botanical Garden, Bogor, West Java Lake soil 
1990 Botanical Garden, Bogor, West Java Lake soil 
BL Beach, Lampung Sand 
BLS Beach, Lampung Seaweed 
BKB Beach, West Kalimantan Sand 
BP Beach, Papua Sand 
BB Beach, Bali Sand 
MKB Mangrove, West Kalimantan Soil 
2111 Mangrove, Jakarta Soil 
2112 Mangrove, Jakarta Soil 
2113 Mangrove, Jakarta Dead wood 
2114 Mangrove, Jakarta Bark 
2115 Mangrove, Jakarta Soil 
2116 Mangrove, Jakarta Bark 
2117 Mangrove, Jakarta Dead wood 
2118 Mangrove, Jakarta Soil 
2119 Mangrove, Jakarta Soil 
2120 Mangrove, Jakarta Dead tree fungi 
2121 Mangrove, Jakarta Soil 
2122 Mangrove, Jakarta Dead wood 
2123 Mangrove, Jakarta Soil 
2124 Mangrove, Jakarta Soil 
2125 Mangrove, Jakarta Soil 
2126 Mangrove, Jakarta Dead leaves 
2127 Mangrove, Jakarta Soil 
2128 Mangrove, Jakarta Soil 
2129 Mangrove, Jakarta Soil 
2130 Botanical Garden, Bogor Wood flour 
2131 Botanical Garden, Bogor Dead roots 
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2132 Botanical Garden, Bogor Moss 
2133 Botanical Garden, Bogor Soil 
2134 Botanical Garden, Bogor Dead wood 
2135 Botanical Garden, Bogor Wood chips 
2136 Botanical Garden, Bogor Dead wood 
2137 Botanical Garden, Bogor Soil 
2138 Botanical Garden, Bogor Bark 
2139 Botanical Garden, Bogor Soil 
2140 Botanical Garden, Bogor Moss 
2141 Botanical Garden, Bogor Soil 
2142 Botanical Garden, Bogor Soil 
2143 Botanical Garden, Bogor Soil 
2144 Botanical Garden, Bogor Soil 
2145 Botanical Garden, Bogor Soil 
2146 Botanical Garden, Bogor Soil 
2147 Botanical Garden, Bogor Soil 
2148 Botanical Garden, Bogor Dead roots 
 
2.1.4 Organisms 
Table 7. Actinobacteria strains from Research Center for Biotechnology LIPI-Indonesia. 
Strain Location of source 
BLH 12-3 Bitung, North Sulawesi, Indonesia 
DHE 2-1 Enggano Island, Bengkulu, Indonesia 
DHE 9-4 Enggano Island, Bengkulu, Indonesia 
MAE 1-3 Enggano Island, Bengkulu, Indonesia 
MAE  1-11 Enggano Island, Bengkulu, Indonesia 
SHP 1-2 Enggano Island, Bengkulu, Indonesia 
SHP 1-4 Enggano Island, Bengkulu, Indonesia 
SHP 1-5 Enggano Island, Bengkulu, Indonesia 
SHP 1-6 Enggano Island, Bengkulu, Indonesia 
SHP 2-2 Enggano Island, Bengkulu, Indonesia 
SHP 2-4 Enggano Island, Bengkulu, Indonesia 
SHP 2-5 Enggano Island, Bengkulu, Indonesia 
SHP 6-2 Enggano Island, Bengkulu, Indonesia 
SHP 6-3 Enggano Island, Bengkulu, Indonesia 
SHP 6-4 Enggano Island, Bengkulu, Indonesia 
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SHP 6-5 Enggano Island, Bengkulu, Indonesia 
SHP 6-6 Enggano Island, Bengkulu, Indonesia 
SHP 7-1 Enggano Island, Bengkulu, Indonesia 
SHP 7-3 Enggano Island, Bengkulu, Indonesia 
SHP 7-5 Enggano Island, Bengkulu, Indonesia 
GKRL-2 Lampung, Indonesia 
GKRL-3 Lampung, Indonesia 
GKRL-4 Lampung, Indonesia 
GBSL-9 Lampung, Indonesia 
 
Table 8. Tested organisms for antimicrobial, antinematode, and cytotoxic activity. 
Organism Code or comment 
Microbes   
Escherichia coli DSM 1116 
Escherichia coli TolC Deficient of TolC (the outer membrane channel for 
multidrug efflux) 






Obtained from PD Dr. Markus Bischoff, 
Saarland University Hospital, Homburg 
Bacillus subtilis DSM 10 




Mucor hiemalis DSM 2656 
Pichia anomala DSM 6766 
Candida albicans  DSM 1665 
Mammalian cells  
A-431  Human epidermoid carcinoma 
A-549  Human lung carcinoma 
Huh-7.5  Human hepatocellular carcinoma cell 
HUVEC  Human umbilical vein endothelial cell 
KB-3-1  Human cervix carcinoma 
L-929  Murine fibroblast 
MCF-7 Human breast adenocarcinoma 
PC-3  Human prostate carcinoma 
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SK-OV-3  Human Caucasian ovary adenocarcinoma 
Nematode  
Caenorhabditis elegans Non-parasitic roundworm 
 
2.1.5 Kits and enzymes 
Table 9. The list of kits and enzymes used in the experiment. 
Kits or enzymes Usage Manufacturer 
Invisorb® Spin Plant Mini 
Kit 
DNA extraction Stratec/Invitek 
NucleoSpin® Microbial DNA DNA extraction Macherey-Nagel 
NucleoSpin® Gel and PCR 
Clean-up 




Nuclease P1 from Penicillium 
citrinum 
DNA digestion  Sigma-Aldrich 
Lysozyme from chicken egg 
white 
Peptidoglycan lysis Sigma-Aldrich 
Proteinase K Protein digestion in DNA 
extraction 
Carl Roth 
Bacterial alkaline phosphatase 
 
Removing 3 and 5 
phosphates from DNA and 
RNA  
Thermo Fisher Scientific 










Some primers are used for 16S rRNA analysis and multi locus sequence analysis 
(MLSA) (Table 10 and Table 11). 
Table 10. The list of primers used for 16S rRNA analysis. 
Primer Sequence (5’ -> 3’) Length (nt) Positiona Reference 
F27 AGA GTT TGA TCM TGG 
CTC AG  
20 8-27 122,148 
R518 CGT ATT ACC GCG GCT 
GCT GG 
20 518-537 149 
F1100 YAA CGA GCG CAA CCC 15 1100-1114 150 
R1100 GGG TTG CGC TCG TTG 15 1100-1114 150 
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R1492 TAC GGY TAC CTT GTT 
ACG ACT T 
22 1492-1513 122,148 
R1525 AAG GAG GTG ATC CAG 
CCG CA 
20 1522-1541 150 
a Position number refers to the 16S sequence of E. coli rrnB (GenBank J01695128). 
Table 11. The list of primers used for multi locus sequence analysis or MLSA. 





GTC GGC GAC TTC ACC AAG GGC 




GTG AAC TGC TTG GCG ACG TGG 




ACC AAG GGC AAG GTG TTC AA  20 151 
 atpDR 
(sequencing) 





TC GAG GGT CTG GAC GCG GTC 




GAA GGT CTT CAC CTC GGT GTT 




GCA AGC GAC CCG GTA TGT AC  20 131,152 
 gyrBRA 
(sequencing) 
GAG GTT GTC GTC CTT CTC GC 20 131,152 
recA recAPF 
(amplification) 
CCG CRC TCG CAC AGA TTG AAC 




GCS AGG TCG GGG TTG TCC TTS 




ACA GAT TGA ACG GCA ATT CG 20 151 
 recAPR2 
(sequencing) 
GCS AGR TCG GGG TTG TCC TTS 




GAG CGC ATG ACC ACC CAG GAC 




CCT CGT AGT TGT GAC CCT CCC 




TTC ATG GAC CAG AAC AAC C  19 151 
 rpoBR1 
(sequencing) 
CGT AGT TGT GAC CCT CCC 18 151 






GCG CGA GGA CCT GAA CCA CAC 




TCG ATG GCC GGG ATG ATG CCC 




GGC TCA CAC AAG ATC AAC AA  20 151 
 trpBR 
(sequencing) 
TCG ATG GCC GGG ATG ATG CC 20 151 
 
2.1.7 Equipment 
Table 12. Equipment used in this work. 
Equipment Manufacturer 
Centrifuge Eppendorf Centrifuge 5804 R 
Centrifuge Eppendorf Centrifuge 5427 R 
Clean Bench Thermo Scientific Type MS 2020 1.2 
CO2 incubator Thermo Scientific Heracell 150i CO2 
Incubator 
HPLC  Agilent 1260 Series; Aligent technology, 
USA 
HPLC Aligent 1100 series; Aligent technology, 
USA 
HPLC column XBrigde® C-18 3.5 µm, 2.1 mm x 100 
mm, Waters 
Incubator Hereus Instruments Function Line 
Light microscope Zeiss Axio Sc pie. A1 microscope 
MS (HRESIMS) 
 
MaXis ESI-TOF-MS spectrometer 
(Bruker) equipped with an Agilent 1260 
series RP-HPLC system 
Multichannel pipette  RAININ 8-Kanal-Pipette ED P3 Plus 
100-1200 µL  
N2 dryer (plates) MiniVap (porvair science) 
Photometer IMPLEN Nano Photometer UV / VIS 
Spektralphotometer 
Pipettes Eppendorf Research plus  
Rotary evaporator Heidolph Laborata 4003 
Shaker Pilot-Shake System Kühner RC-6-U  
Shaker (plates) Heidolph Titramax 1000 
Thermocycler Eppendorf Thermocycler Mastercycler 
gradient  
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Thin layer chromatography (TLC) plates 
cellulose 
Merck 
Thin layer chromatography (TLC) plates 
silica gel 60 
Merck 
UV detector  Herolab RH-5.1 darkroom hood + B-
1393-3K7N camera 
DNA sequencer 96-capillary-system from Applied 
Biosystems (ABI), 3730xl DNA 
Analyzer. 
 
2.2 Methods  
2.2.1 Sampling 
The samples were taken by the members of the GINAICO (German-Indonesian Anti-
Infective Cooperation) team:  Dr. Tjandrawati Mozef, Dr. Kathrin I. Mohr, Dr. Enge 
Sudarman, and Senlie Octaviana from 2015 until 2017. The locations range from the 
western part of Indonesia until the eastern part of Indonesia such as Lampung in 
Sumatra Island; West Kalimantan in Kalimantan Island; Jakarta, Bogor, Cimahi, and 
Malang in Java Island; Bali Island; Kendari in Sulawesi Island; Papua Island  (Figure 
5).  
2.2.2 Isolation of Actinobacteria 
One gram of samples was heated at 60°C for 30 minutes to eliminate all the vegetative 
cells. After the temperature decreased, ten milliliters of sterile water were added to the 
samples. The mixtures then were serially diluted until a dilution of 1:1000. The 
samples were plated on agar medium 5336 supplemented with cycloheximide 100 
(µg/ml) as antifungal agent153 and incubated for 7-21 days at 30°C.   
2.2.3 Extract Production 
The precultures were cultivated in 100 ml of GYM or GYM+ASW medium in a 250 
mL flask for five days at 30°C and 160 rpm on a rotary shaker then were transferred 
1:10 to 100 mL of SYP, 5254, 5295, 5254+ASW, and 5294+ASW for metabolite 
production. The cultures were incubated further for 5-7 days at 30°C and 160 rpm. 
Afterward, 20 ml of the cultures were extracted with 20 ml of ethyl acetate and were 
centrifuged at 9000 rpm for 10 min to separate the phases between the two immiscible 
solvents. The upper phase was then transferred and evaporated with reduced pressure 
at 40°C. The extract was re-dissolved in 1 ml of ethyl acetate: acetone: methanol 
(1:1:1) 138,154. 










Figure 5. Map of Indonesia with the sampling sites.The sampling locations are marked 
with a red circle. Credit picture from https://pasarelapr.com/images/map-of-indonesian-
island/map-of-indonesian-island-6.png 
 
2.2.4 Analysis of 16S rRNA sequences 
Genomic DNA extraction was performed by using Invisorb Spin Plant Mini Kit (250) 
(Stratec Molecular, Germany). From the well-grown cell suspension, 500 µl were 
taken and centrifuged for 2 minutes at 11,000 rpm. The supernatant was discarded and 
the cell pellet was mixed with 100 µL of lysis buffer. The mixture was then incubated 
at 95 °C for 5 min and added again with 300 µL lysis buffer. Afterward, 20 µL protein 
kinase K were added and incubated for 30 min at 65°C. The remaining steps were 
conducted following the manufacturer’s instruction. 
Amplification of 16S rRNA genes and the purification of the PCR product were 
carried out using the methods described by Mohr et al.155. Two primers were used 
matching most of the known eubacterial orders on the positions 27 (forward) and 1492 
(reverse) or 1525 (reverse). The reaction volume (50 µl) was created containing water 
(22 µl), primers (1 µl; 10 µM each), “Jump Start Ready Mix” or JSRM (25 µl) and 
template DNA (1 µl). The JSRM is a mixture of JumpStart Taq DNA polymerase, 
99% pure deoxynucleotides and buffer in an optimized reaction concentrate. The PCR 
reaction was conducted in a Mastercycler Gradient (Eppendorf, Hamburg, Germany). 
The condition of reaction included: initial denaturation at 95°C (5 min); 34 cycles of 
denaturing at 94°C (30 s); annealing at 52°C (30 s); elongation at 72°C (120 s); final 
elongation at 72°C (10 min).  
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The PCR product was checked on the agarose gel (0.8%) and purified using the 
NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel, Germany) following the 
manufacturer’s protocol. The DNA sequencing was performed by using 96-capillary-
system from Applied Biosystems (ABI), 3730xl DNA Analyzer. The primers for 
sequencing were F27, R518, F1100, R1100, and R1492 or R1525. 
Identification of phylogenetic neighbours and calculation of pairwise 16S rRNA gene 
sequence similarities were performed using EzTaxon-e server (http://www. 
ezbiocloud.net/taxonomy)156 and the sequences of the strains were aligned using the 
CLUSTAL W algorithm157 from the MEGA X software package158. Phylogenetic 
analysis was achieved using the maximum-likelihood159, maximum-parsimony160 and 
neighbour-joining161 algorithms from MEGA X158. The topologies of the inferred trees 
were evaluated by bootstrap analyses162 based on 1000 replicates. 
2.2.5 Morphology and melanin production 
The morphological characteristics of the strains and the ability to produce melanin 
were examined by incubating them on ISP2 (International Streptomyces Project 2), 
ISP3, ISP4, ISP5, ISP6, ISP7 medium, SSM+T (synthetically Suter medium with 
tyrosine), and SSM-T (synthetically Suter medium without tyrosine)102,163 after 14 
days at 30°C. The colors of aerial and substrate mycelium, as well as the diffusible 
pigments, were determined by comparison with the RAL-code (https://www.ral-
farben.de)138. Spore chain morphology and spore-surface ornamentation were 
observed after 14-30 days at 30°C on ISP 3 medium102.  A block of agar (1 cm x 1 cm) 
containing bacteria with the spores was fixed in glutaraldehyde solution (5%)164. The 
sample was then critical-point-dried and gold–palladium-sputtered. Afterward, the 
morphology of the spores was observed by a Zeiss Merlin field emission scanning 
electron microscope (FESEM) with an Everhart-Thornley SE-detector and an Inlens-
SEM detector in a 25:75% ratio applying the SEMSmart software version 5.05109. 
SEM analysis was done by Prof. Dr. Manfred Rhode, HZI Braunschweig. 
2.2.6 Physiological and biochemical characteristic 
2.2.6.1 Growth at different temperature and pH 
Growth at different temperatures (15, 20, 25, 30, 37 and 44°C) on GYM medium agar 
and pH range (pH 2, 3, 4, 5, 6, 7, 8, 9 and 10) on ISP 2 medium liquid were observed 
after incubation for 14 days.  
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2.2.6.2 Carbon utilization 
Carbon utilization was studied on basal medium for carbohydrate utilization or ISP 9 
medium102 containing 10 different carbon sources (1 %, w/v) such as glucose, 
arabinose, sucrose, xylose, inositol, mannitol, fructose, rhamnose, raffinose, and 
cellulose. For this study, 12-well flat bottom plate was used.  
2.2.6.3 Sodium chloride tolerance 
The sodium chloride tolerance study was based on the method of Kutzner et al.165 with 
different concentration of NaCl: 0%, 2.5%, 5.0%, 7.5%, and 10%. In this examination, 
the 6-well flat bottom plate was employed.  
2.2.6.4 Enzymatic assay 
The enzyme profiles were studied by using API ZYM166 and API Coryne strips167. At 
least five days old liquid culture of the bacteria were used for this study. The enzymes 
that can be detected with API ZYM and API Coryne system are listed in Table 13. 
 
Table 13. The activities that can be analyzed by API ZYM and API Coryne. 
API ZYM API Coryne 
Alkaline phosphatase Nitrate reduction 
Butyrate esterase (C4) Pyrazinamidase 
Caprylate esterase lipase (C8) Pyrrolidony arylamidase 
Myristate lipase (C14) Alkaline phosphatase 
Leucine arylamidase β-glucuronidase 
Valine arylamidase β-galactosidase 
Cystine arylamidase α-Glucosidase 
Trypsin N-acetyl-β-glucosamidase 
α-Chymotrypsin Esculin (β-glucosidase) 
Acid phosphatase Urease 
Naphtol-AS-BI-phosphohydrolase Gelatine (hydrolysis) 
α-Galactosidase Glucose fermantation 
β-Galactosidase Ribose fermentation 
β-Glucoronidase Xylose fermentation 
α-Glucosidase Mannitol fermentation 
β-Glucosidase Maltose fermentation 
N-acetyl-β-glucosaminidase Lactose fermentation 
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α-Mannosidase Sucrose fermentation 
α-Fucosidase Glycogen fermentation 
 
2.2.6.5 Antibiotic susceptibility 
Antibiotic susceptibility was evaluated by the disc-diffusion plate method137 using 
antibiotic discs on ISP 2 agar medium incubated at 30°C for 7 days. One loop of 
bacteria from the agar plate or 100 µl of 5-7 days old liquid culture were diluted with 
1 ml sterile water and 100 µl of the suspension was plated on the ISP 2 agar medium. 
Eight antibiotic discs were used: ampicillin (10 µg/disc), erythromycin (15 µg/disc), 
gentamycin 30 (µg/disc), tetracycline (30 µg/disc), vancomycin (30 µg/disc), 
cefotaxime (30 µg/disc), rifampicin (5 µg/disc), and penicillin G (6 µg/disc). 
2.2.7 Chemotaxonomy 
2.2.7.1 Freeze-dried cells preparation  
For chemotaxonomy study, freeze-dried cells were used instead of the wet biomass to 
ease the extraction of chemical substances from the cells. The biomass of a 5-7 days 
old grown culture in the medium GYM, ISP2 or TSB was collected by centrifuge at 
9000 rpm for 10 minutes. The pellet was washed three times with demineralized water 
and centrifuged three times at 9000 rpm for 10 minutes. The wet biomass was freeze-
dried for two days. 
2.2.7.2 Cell wall amino acid analysis 
The cell wall amino acid analysis was carried out as described by Staneck and 
Roberts168. Freeze-dried cells (3 mg) and 200 µl of 20% HCl or 6N HCl were added 
to a 4 ml brown glass vial. The vial was tightly closed with the lid and heated at 100°C 
for 18h. The mixture was cooled down and filtered by Whatman filter paper. The 
filtrate was evaporated at 100°C. Demineralized water (500 µl) was added and the 
liquid was dried again at 100°C to remove the remains of HCl. The dried extract was 
dissolved with 100 µl demineralized water. The amount of 2 µl was applied for TLC 
(Thin Layer Chromatography) analysis using an aluminium-backed cellulose plate. 
The mobile phase was methanol- demineralized water -6 N HCl-pyridine (80:26:4: 10, 
vol/vol). Standard amino acid (1 µl, 5 mg/ml) was diaminopimelic acid. Spots of 
amino acids were visualized by spraying with ninhydrin and heating at 100°C for 3 
min. 
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2.2.7.3 Whole-cell sugar analysis 
The whole-cell sugars analysis were prepared following the method of Staneck and 
Roberts168. Freeze-dried cells (25 mg) and 1.5 ml of 2.5% H2SO4 or 1N H2SO4 were 
added to a 4 ml brown glass vial. The vial was tightly closed with the lid and heated 
at 100°C for 2 h. After cooling down, the hydrolysate was transferred to a 15-ml 
conical centrifuge tube, and saturated barium hydroxide (Ba(OH)2. H2O = 3 gr/10 ml) 
was added carefully until the pH reached 5.2 and 5.5 (determined with pH paper). The 
precipitate was removed by centrifugation (9000 rpm, 5 min) and discarded. The 
supernatant fluid was evaporated at 35°C with nitrogen flow, and the residue was 
redissolved with 100 µl demineralized water. The amount of 2 µl was applied for TLC 
analysis using aluminium-backed cellulose plate. The mobile phase was n-butanol-
demineralized water-pyridine-toluene (10:6:6:1, vol/vol). Two standards containing 
mixtures of sugar were employed because of the closely Rf value (retention factor) 
between the sugar. The first mixed sugar standard (0.5 µl, 10 mg/ml each) contained 
galactose, arabinose, and xylose. The second mixed sugar standard (0.5 µl, 10 mg/ml 
each) comprised rhamnose, mannose, glucose, and ribose. Spots of sugars were 
visualized by spraying with acid aniline phthalate and heating at 100°C for 5 min. 
2.2.7.4 Menaquinone analysis 
Menaquinones were extracted following the procedure performed by Minnikin et 
al.169. Freeze-dried cells (100 mg) were transferred into polytetrafluoroethene capped 
tube. The amount of 4 ml methanol-0.3% aqueous NaCl (90:10) and 4 ml petroleum 
ether were added to the tube. The suspension was mixed on tube rotator for 30 min. 
The upper phase was transferred to evaporator tube. The same amount of new 
petroleum ether was added again to the lower phase and mixed on tube rotator for 30 
min. The upper layers were combined and evaporated at 30°C with reduced pressure 
until the volume remains about 1 ml. The extract was transferred to the 4 ml brown 
glass vial and dried at 30°C under N2 flow. The dry extract was re-dissolved with 100 
µl acetonitrile-isopropanol (65:35). The menaquinones were analyzed by high-
performance liquid chromatography103 equipped with diode-array detection and mass 
spectrometry (HPLC-DAD-MS). Here, high-resolution electron spray ionization mass 
spectrometry (HR-ESI-MS) data were recorded on a MaXis ESI-TOF-MS 
spectrometer (Bruker) equipped with an Agilent 1260 series RP-HPLC system. The 
HPLC system consisted of XBridge C18 column 2.1 x 100 mm, 1.7µm; solvent A was 
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isopropanol and solvent B was acetonitrile. The gradient system was 100% B for 3 
min, 35% B in 5 to 15 min, and 50% B in 16-20 min. The flow rate was 0.6 mL/min, 
temperature of column was 40°C, and the UV-detection was at 270 nm. Molecular 
formula was calculated using the Smart Formula algorithm including the isotopic 
pattern (Bruker).  
2.2.7.5 Polar lipid analysis 
The polar lipids were extracted by the method of Minnikin et al.170 and identified by 
two-dimensional thin-layer chromatography as described by Collins and Shah111. 
Freeze-dried cells (200 mg) were transferred into a polytetrafluoroethene capped tube. 
The amount of 8 ml Chloroform-MeOH (2:1) was added to the tube and mixed on tube 
rotator for 16 h. The suspension was filtered with filter paper and washed 2 times with 
2 ml Chloroform-MeOH (2:1). The filtrate was combined to evaporation flask (25 ml 
volume size) and was evaporated with reduced pressure at 30°C. The extract was 
redissolved with 200 µl Chloroform-MeOH (2:1) and transferred to 0.3 ml brown glass 
vial.  
Examination of polar lipids was conducted by two-dimensional thin-layer 
chromatography (TLC) using HPTLC Kieselgel 60F254 (Merck) plate (10 x 10 cm). 
The two‐dimensional thin‐layer chromatography was applied in this analysis. The first 
dimension was with chloroform/methanol/water (65:25:4 by volume) and in the 
second dimension was with chloroform/methanol/ acetic acid/water (80:12:15:4 by 
volume). For detecting all lipids, 10% molybdophosphoric acid in ethanol was sprayed 
to the plate and heated at 140°C for 15 min. Observation of specific lipid was carried 
out by spraying different reagents. Ninhydrin solution was used for detecting free 
amino groups (100°C, 4 min), molybdenum blue for phosphate-containing lipids, α-
naphtol-H2SO4, anisaldehyde spray solution reagent (100°C, 10 min) for sugar-
containing lipids, and Dragendorffs reagent for quaternary ammonium groups (Table 
5). 
2.2.7.6 Fatty acid analysis 
Fatty acids were extracted, methylated and analyzed using Sherlock Microbial 
Identification (MIDI) system and the ACTIN version 6 database171. Freeze-dried cells 
(10 mg) were transferred into 13 x 100 culture tube. The amount of 1 ml saponification 
reagent (45 g NaOH, 150 ml methanol, 150 ml distilled water) was added to the tube. 
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The tube was sealed with teflon lined cap, vortexed and heated in a boiling water bath 
for 5 minutes. It was vortexed again for 5-10 minutes and returned to the boiling water 
bath to accomplish the 30-minute heating. The mixture was cooled into room 
temperature and added by 2 ml methylation reagent (325 ml HCl 6N, 275 ml 
methanol). The tube was capped, briefly vortexed, and heated for 10 minutes at 80°C. 
The mixture was cooled down into room temperature and added by 1.25 ml extraction 
reagent (200 ml hexane and 200 ml methyl tert.-butyl ether). The tube was recapped 
and tumbled on a rotator for 10 minutes. The tube then was uncapped and the aqueous 
phase (lower part) was pipetted out and discarded. About 3 ml of washing reagent 
(10.8 g NaOH dissolved in 900 ml distilled water) was added to the organic phase. 
The tube was recapped and tumbled for 5 minutes. About 2/3 of the organic phase 
(upper part) was pipetted into a GC vial for analysis. GC analysis was carried out with 
the conditions: using 25 m x 0.2 mm phenyl methyl silicone fused silica capillary 
column, the temperature program increased from 170°C to 270°C at 5°C per minute, 
employing flame ionization detector (FID), the carrier gas was hydrogen and the 
“make up” gas was nitrogen. Fatty acid analysis was conducted by Gabriele Pötter and 
Dr. Richard Hahnke, Leibniz Institut DSMZ-Braunschweig.  
2.2.8 G+C (guanine + cytosine) contents determination  
Genomic DNA for G+C contents analysis was prepared based on procedure conducted 
by Rong and Huang172 with some modification. Twenty milliliters of well-grown 
culture were taken, centrifuged, washed three times with demineralized water and 
suspended in 10 ml STE buffer (75 mM NaCl, 25 mM Tris–HCl, 25 mM EDTA, pH 
8.0) containing 5 mg lysozyme. Glass beads were added to the suspension and the 
mixture was vortexed to homogenize the cells. Afterwards, the suspension was 
incubated for 1 h at 37oC in the tube rotator. The cells were completely lysed by adding 
0.2 ml 20% (w/v) SDS and the lysate was further incubated at 55oC for 2 h in the tube 
rotator. The DNA was extracted with the addition of chloroform (1:1, by volume) and 
the tube was centrifuged 9000 rpm for 10 minutes. The polar part (upper layer) was 
transferred carefully to the new tube and was added by 0.1 volume of 3 M sodium 
acetate (pH 5.5). The genomic DNA was precipitated with the addition 1 volume of 
isopropanol, rinsed two times with 70% ethanol, dried and dissolved in 1 ml of 
nuclease-free water.  
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The G+C content analysis was carried out adapting the method of Tamaoka and 
Komagata173 and Mesbah et al.118. DNA solution containing 0.4-1.0 mg/ml in 
nuclease-free water was heated at 100°C for 10 minutes and cooled rapidly in an ice 
bath for 5 minutes. The denatured DNA solution was mixed with 16 µl of 30 mM 
sodium acetate buffer (pH 5.3), 2 µl of 20 mM ZnSO4, and 2 µl of P1 nuclease (1 
mg/ml in sodium acetate buffer; 340 U/ml). The mixture was incubated at 50oC for 1 
h. Afterwards, 18 µl Tris Buffer 0.1 M pH 8.1 and 2 µl of Bacterial Alkaline 
Phosphatase (2.5 U/µl) was added to the mixture and incubated further at 65oC for 1 
h. The hydrolysate was centrifuged at 11,000 rpm for 5 min and was transferred to 0.3 
ml brown glass HPLC vial.  
The HPLC system consisted of XBridge C18 column 2.1 x 100 mm, 1.7µm; solvent 
A was ammonium acetate buffer 5 mM and solvent B was acetonitrile/ ammonium 
acetate buffer 5 mM (95:5). The gradient system was 100% A to 95% A for 2 min, 
95% A to 80% A for 4 min, 80% A to 60% A for 2 min and isocratic condition of 60% 
A for 2 min. The flow rate was 0.3 mL/min, the temperature of the column was 40°C, 
and the UV-detection was at 270 nm.  
2.2.9 Multilocus sequence analysis (MLSA) for Streptomyces sp. SHP 1-2.  
Genomic DNA extraction was performed by using Invisorb Spin Plant Mini Kit (250) 
(Stratec Molecular, Germany). From the well-grown cell suspension, 500 µl were 
taken and centrifuged for 2 minutes at 11,000 rpm. The supernatant was discarded and 
the cell pellet was mixed with 100 µL of lysis buffer. The mixture was then incubated 
at 95°C for 5 min and 300 µL lysis buffer were added. Afterwards, 20 µL protein 
kinase K was added and incubated for 30 min at 65°C. The remaining steps were 
conducted following the manufacturer’s instruction. 
Five housekeeping genes for multilocus sequence analysis (MLSA), atpD, gyrB, recA, 
rpoB, and trpB, were used as reported previously by Guo et al.151. The gene atpD is 
responsible for expressing ATP synthase F1 beta subunit. The gene gyrB is for 
producing DNA gyrase B subunit. The gene recA is responsible for recombinase A 
expression. The genes rpoB and trpB are for preparing RNA polymerase beta subunit, 
and tryptophan synthase beta subunit, respectively130. The partial sequences of the five 
housekeeping genes were amplified and sequenced by using the primers based on the 
method of Guo et al.151, Rong et al.130, and Labeda et al.24 (Table 11). The sequences 
of the five housekeeping genes were concatenated from head to tail and then aligned 
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using MUSCLE174 in MEGA X158. The phylogenetic relationships were calculated 
using the maximum-likelihood159, maximum-parsimony160 and neighbour-joining161 
algorithms in MEGA X158. The MLSA distance was determined using Kimura 2-
parameter distance175. The topologies of the inferred trees were evaluated by bootstrap 
analyses162 based on 1000 replicates. The MLSA distance 0.007 is suggested 
previously equivalent to 70% DNA-DNA relatedness value130. That means the MLSA 
distance greater than 0.007 is considered as different species.  
2.2.10 Bioactivity assay 
2.2.10.1 Antimicrobial assay 
Antimicrobial activity test was conducted by serial dilution in 96-well plates16. All the 
wells were filled with 150 µL of the microbial suspension (OD600 0.01 for bacteria 
and 0.05 for fungi). The first row was filled with another 130 µL of the suspension of 
the test trains. Then 20 µL of the compound were added to the first row and the sample 
was serially diluted with two-fold dilution to the next row until the last row. In the last 
row, 150 µL extra were discarded so that the volume of the suspension in all wells are 
the same (150 µL). The bacterial test strains were Escherichia coli DSM 1116, 
Escherichia coli TolC, Chromobacterium violaceum DSM 30191, Pseudomonas 
aeruginosa DSM 19882, Staphylococcus aureus Newman, Bacillus subtilis DSM 10, 
Micrococcus luteus DSM 1790, and Mycobacterium smegmatis ATCC 700084. The 
fungal test strains were Mucor hiemalis DSM 2656, Pichia anomala DSM 6766, and 
Candida albicans DSM 1665. The plates were incubated for 24-48 hours at 30°C or 
37°C. A clear well was considered to show inhibition of microbial growth. Inhibition 
in A-B rows was considered as low activity, C-E rows were medium activity, and F-
H rows were strong activity.  
2.2.10.2 Nematicidal actitity 
The nematicidal activity against Caenorhabditis elegans was determined by as 
described by Rupcic et al.176. The amount of 500 nematodes/ml in M9 buffer (NaCl 5 
g/l, Na2HPO4.2H2O 7.5 g/l, KH2PO4 3 g/l, MgSO4.7H2O 0.25 g/l, pH 7.2) and 66 µl 
of the tested compound were added in 24-well plate. The plates were then incubated 
at 20°C for 18 h. The dead and alive worms were counted using a microscope and a 
mechanic counter.    
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2.2.10.3 Cytotoxic assay 
In vitro cytotoxicity assay was carried out based on the method of Landwehr et al.154. 
The cell lines for the assay were L-929 (murine fibroblast), KB-3-1 (human cervix 
carcinoma), A-549 (human lung carcinoma), PC-3 (human prostate carcinoma), MCF-
7 (human breast adenocarcinoma), A-431 (human epidermoid carcinoma), SK-OV-3 
(human Caucasian ovary adenocarcinoma), and HUVEC (human umbilical vein 
endothelial cell). The cells were grown at 37°C and 5% CO2 in Dulbecco’s modified 
Eagle’s medium (DMEM; high glucose) supplemented with 10% FCS (fetal calf 
serum). Then, 60 µl of serial dilutions of the test compounds were added to 120 µL of 
suspended cells (50,000 cells/mL) in the wells of 96-well plates. After five days of 
incubation, the inhibition of propagation (IC50) was determined using an MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The cytotoxic assay 
was conducted by Wera Collisi, HZI-Braunschweig.  
2.2.10.4 Antiviral assay 
The antiviral assay was conducted according to Mulwa et al.177. Huh-7.5 cells (human 
hepatocellular carcinoma cells) stably expressing Firefly luciferase (Huh-7.5 Fluc) 
were inoculated with RLuc Jc1 reporter viruses and the extracts were given also to the 
cells. The cells were incubated at 37°C with 5% CO2 supply. After 4 hours of 
incubation, the inoculum was discarded and the cells were washed with PBS 
(phosphate buffer saline) and were added with new medium without extracts. The 
medium for the cells was Dulbecco’s modified minimum essential medium (DMEM, 
Life Technologies Manchester UK) containing 2 mM glutamine, 1 × minimum 
essential medium nonessential amino acids (MEM NEAA, Life Technologies), 100 
μg/mL streptomycin, 100 IU/mL penicillin (Life Technologies), 5 μg/mL blasticidin 
and 10% FBS (fetal bovine serum). After 3 days of incubation, the infected cells were 
lysed. The reporter virus infection and the cell viability was determined by renilla 
luciferase and firefly luciferase activity, respectively. The measurement of luciferase 
activity was performed by using Berthold Technologies Centro XS3 Microplate 
Luminometer. The antiviral assay was conducted by Dimas F. Praditya and Prof. Dr. 
Eike Steinmann, TWINCORE-Hannover. 
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2.2.11 Fermentation, extraction and isolation of secondary metabolites from 
Streptomyces sp. SHP 1-2 
The pre-culture of strain SHP 1-2 was grown in 250 mL Erlenmeyer flasks containing 
100 mL GYM medium154 for 5 days at 30oC on a rotary shaker (160 rpm). The 
inoculum was transferred (1:10, by volume) into 500 mL Erlenmeyer flasks containing 
200 mL 5294 medium154. A total of 10 L of liquid medium was cultivated at 30oC for 
5 days on the shaker with 160 rpm.  
The fermentation broth (10 L) was harvested after 5 days of incubation and was 
centrifuged at 8500 rpm for 30 minutes. Afterwards, 5% (v/v) XAD-2 polymeric resin 
suspension was added to the filtrate and was stirred slowly for 16 hours in dark 
condition. The mycelium was extracted with 500 ml of acetone for three times. The 
extracts were combined and concentrated at 40°C with reduced pressure until the 
aqueous residue. This residue then partitioned with n-heptane and ethyl acetate 
respectively to yield n-heptane extract (63 mg) and ethyl acetate extract (781 mg). The 
solid residue from the mycelium was extracted again with ethyl acetate, evaporated at 
40°C with reduced pressure, re-dissolved with methanol, and partitioned with n-
heptane. The methanol extract then evaporated at 40°C under vacuum to give methanol 
extract (63 mg). The n-heptane extract (63 mg), ethyl acetate extract (781 mg), and 
methanol extract (63 mg) were combined and fractionated by a silica gel 
chromatography column eluting with gradient of CH2Cl2-ethyl acetate (from 100:0 to 
0:100, by volume) to give eight fractions. Fraction 4 and fraction 7 were introduced 
separately to preparative reversed-phase HPLC using a C18 column with the gradient 
system (from 10% Acetonitrile: 90% Water to 100% Acetonitrile, by volume) to yield 
fraction 4.1 (35 mg) and fraction 7.1 (70 mg). The fermentation, extraction, and 
isolation of compound were carried out together by Dr. Rizna T. Dewi (RChem LIPI, 
Serpong), Gian Primahana, and Dr. Enge Sudarman (HZI-Braunschweig). 
2.2.12 Fermentation, extraction and isolation of compound from Amycolatopsis 
sp. 196526CR 
The pre-culture of strain 196526CR was grown in 250 mL Erlenmeyer flasks 
containing 100 mL GYM medium154 for 5 days at 30oC on a rotary shaker (160 rpm) 
and the inoculum was transferred (1:10, by volume) into 250 ml Erlenmeyer flasks 
containing 100 ml, 500 ml Erlenmeyer flasks containing 200 ml, or 1000 ml 
Erlenmeyer flasks containing 400 mL 5294HG-S medium (Table 4). A total of 15 L 
of liquid medium was cultivated at 30oC for 7 days in the shaker 160 rpm.  
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The fermentation broth (15 L) was harvested after 7 days of incubation and centrifuged 
at 8500 rpm for 30 minutes. Afterwards, 5% (v/v) XAD-2 polymeric resin suspension 
were added to the filtrate and was stirred slowly for 16 hours in dark condition. The 
mycelium was extracted with acetone: methanol (1:1) for five times. The extracts were 
combined and concentrated at 40°C with reduced pressure until the aqueous residue. 
The aqueous residue was partitioned with ethyl acetate to yield ethyl acetate extract 
(6.1 g). The ethyl acetate extract was re-dissolved with 95% methanol and partitioned 
with n-heptane and dichloromethane to give n-heptane extract (3.3 g) and 
dichloromethane extract (551.5 mg).  The dichloromethane extract was fractionated 
by an RP-18 chromatography column eluting with gradient of water (with formic acid 
0.1%) and acetonitrile (with formic acid 0.1%) (from 40:60 to 0:100, by volume) to 
give fraction GRP17-19 (8.7 mg). Fraction GRP17-19 was further purified with  RP-
18 chromatography column eluting with gradient of water (with formic acid 0.1%) and 
acetonitrile (with formic acid 0.1%) (from 50:50 to 0:100, by volume) to yield fraction 


















3.1 Isolated Actinobacteria, 16S rRNA gene characterization, and bioactivity 
of the extracts 
There were 196 Actinobacteria strains isolated from Indonesian samples. Twenty four 
of them were already isolated in Indonesia by Dr. Shanti Ratnakomala (Research 
Center of Biotechnology-LIPI). From 196 isolates, 84 strain were analyzed for their 
16S rRNA gene during this work. There were 59 isolates characterized as 
Streptomyces and 25 isolates were non-Streptomyces. Some selected strains with with 
low percentage similarity from the closest type strains are shown in Table 14. There 
were 82 strains used for extract production and tested for antimicrobial activity. Some 
of the extracts, totally 58 extracts, had interesting antimicrobial activity with moderate 
and strong level. Some selected strains that can produce extracts with moderate and 
strong antimicrobial activity can be seen in Table 15. From 101 extracts that were 
tested for antiviral activity, only 46 extracts had promising antiviral activity with 
moderate (20-50% infectivity), strong (3-20% infectivity) and very strong level (< 3% 
infectivity). The nontoxic extracts that have strong antiviral activity against HCV are 
listed in Table 16. 
Table 14. Some isolated Actinobacteria with low percentage similarity from the closest 
species based on 16S rRNA gene 
No. Strain 
 





1 9BLSSO Streptomyces lanatus 97.03 99.9 
2 195336CR Mycobacterium palauense 98.47 100 
3 194938CR Kibdelosporangium 
banguiense  
98.74 100 
4 195105 Streptomyces cyaneus  98.77 50.7 
5 195107 Streptomyces cyaneus  98.77 50.6 
6 195227GnCR Streptomyces filipinensis   98.81 58.0 
7 DHE 9-4 Streptomyces spongiae  98.83 100 
8 196526CR Amycolatopsis thermalba  98.85 100 
9 190122BCR Streptomyces roietensis  98.89 58.2 
10 190233 Streptomyces glomeratus  98.96 33.3 







Table 15. Selected strains that can produce extracts with moderate and strong activity 
against some microbes 
No. Strain Production 
medium 
Antimicrobial activity 
1 SHP 1-2 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (strong) 
Staphylococcus aureus (moderate) 
Micrococcus luteus (strong)  
2 195105 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Bacillus subtilis (strong) 
Staphylococcus aureus (moderate) 
Micrococcus luteus (moderate) 
Mycobacterium smegmatis (moderate) 
Fungi 
Mucor hiemalis (moderate) 
3 195107 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Bacillus subtilis (strong) 
Staphylococcus aureus (strong) 
Micrococcus luteus (moderate) 
Mycobacterium smegmatis (moderate) 
Fungi 
Mucor hiemalis (moderate) 
4 196526CR 
(Amycolatopsis sp.) 
5294 Gram-positive bacteria  




Mucor hiemalis (moderate) 




5254 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria  
Staphylococcus aureus (moderate) 
6 9BLSSO 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Staphylococcus aureus (moderate) 
Fungi 















Table 16. List of non-toxic extracts having antiviral activity with strong level against 
HCV 
No. Strain Extract 
1 DHE 2-1 DHE 2-1_5254 
2 DHE 2-1 DHE 2-1_5294 
3 MAE 1-11 MAE 1-11_5294 
4 MAE 1-11 MAE 1-11_SYP 
5 SHP 1-4 SHP 1-4_5294 
6 SHP 2-2 SHP 2-2_5294 
7 SHP 6-6 SHP 6-6_5294 
8 190231 190231_5294 
9 C190221 C190221_5254 
10 C194911 C194911_5294 
11 C195321A C195321A_5254 
12 C195321A C195321A_5294 
13 C196921 C19692 _5254 
3.2 Polyphasic taxonomy of Streptomyces sp. SHP 1-2 
Morphology and melanin production 
Streptomyces sp. SHP 1-2 grew well on GYM, ISP 2, ISP 3, ISP5, ISP6, ISP7, SSM+T 
and SSM-T medium agar and moderately on ISP 4 medium agar (Table 17). The 
morphology of the strain in GYM and ISP 2 medium can be seen in Figure 6. Scanning 
electron microscopy, after 14 days of growth on ISP 3, showed spiral chains of smooth 
surface spores (Figure 7). 
Table 17. Growth and characteristics of Streptomyces sp. SHP 1-2 cultivated on various 
agar media after incubation for 14 days at 30 °C 









extract (ISP 2) 
Good Olive brown, 
ochre yellow 
Traffic grey B, 
signal white 
None 




starch (ISP 4) 




asparagine (ISP 5) 






extract-iron (ISP 6) 




Tyrosine (ISP 7) Good Ivory light, 
ivory 






Good Ocker brown, 
ivory 




Good Ocher brown, 
ivory 



















Figure 7. Scanning electron micrographs of aerial mycelium and spores of Streptomyces 
sp. SHP 1-2 after incubation on ISP 3 agar for 14 days at 30 °C. 
3.1.1 Chemotaxonomy  
The cell wall of Streptomyces sp. SHP 1-2 comprised of LL-diaminopimelic acid. The 




contained glucose and xylose. The TLC chromatogram for amino acid of the cell wall 
and whole-cell sugar analysis can be seen in (Figure 8). The predominant fatty acids 
of Streptomyces sp. SHP 1-2 were anteiso-C15:0 (29.99%), iso-C16:0 (14.61%), 
anteiso-C17:0 (11.55%), iso-C15:0 (11.16%) and C16:0 (9.24%) (Figure 9). Its major 
menaquinones comprised as MK-9(H4) 9.31%, MK-9(H6) 68.03%, MK-9(H8) 
22.65% in a ratio of 1:7:2 (Figure 10). The polar lipids were detected as 
diphosphatidylglycerol, phosphatidylethanolamine, phosphatidylinositol, 










Figure 8. TLC chromatogram of whole-cell sugar analysis (left) and analysis amino acid 
of the cell wall (right) of Streptomyces sp. SHP 1-2. TLC chromatogram of whole-cell 
sugar analysis (left) and analysis amino acid of the cell wall (right) of Streptomyces sp. 
SHP 1-2. S1: Standard 1; S2: Standard 2; X: Xylose; A: Arabinose; Gal: Galactose; 
DPM: Diaminopimelic acid standard; LL: LL- Diaminopimelic acid; Meso: meso-
Diaminopimelic acid; SHP 1-2: Streptomyces sp. SHP 1-2.   
3.2.1 16S rRNA gene analysis 
The almost complete 16S rRNA gene sequence of Streptomyces sp. SHP 1-2 (1,509 
nucleotides) was determined and deposited under the GenBank accession number 
MK287949. Based on the result from EzTaxon server (http://www. 
ezbiocloud.net/taxonomy)156, the strain was known to be closely related to the type 
strains of Streptomyces viridochromogenes NBRC 3113T (99.03%), Streptomyces 
malachitofuscus NBRC 13059T (99.03%), and Streptomyces misionensis DSM 40306T 




from other 18 close species in the phylogenetic tree based on the 16S rRNA gene 













RFact ECL Peak Name Percent 
1.629 3.712E+8 0.026 ---- 7.011 SOLVENT PEAK ---- 
2.129 255 0.024 ---- 8.003  ---- 
2.537 297 0.020 ---- 8.815  ---- 
2.890 306 0.023 1.194 9.515 unknown 9.521 0.50 
6.738 2374 0.036 0.986 13.618 14:0 ISO 3.17 
6.810 364 0.033 ---- 13.671  ---- 
7.258 389 0.033 0.976 13.998 14:0 0.51 
8.218 8561 0.039 0.962 14.622 15:0 ISO 11.16 
8.358 23054 0.039 0.960 14.713 15:0 ANTEISO 29.99 
9.565 832 0.041 0.948 15.459 16:1 ISO H 1.07 
9.842 11404 0.042 0.946 15.625 16:0 ISO 14.61 
10.160 641 0.041 0.943 15.816 16:1 CIS 9 0.82 
10.463 7248 0.040 0.941 15.998 16:0 9.24 
11.188 1392 0.040 0.937 16.417 16:0 9? METHYL 1.77 
11.370 3079 0.042 0.937 16.522 17:1 ANTEISO C 3.91 
11.555 2388 0.042 0.936 16.629 17:0 ISO 3.03 
11.715 9119 0.042 0.935 16.722 17:0 ANTEISO 11.55 
12.005 3258 0.046 0.934 16.889 17:0 CYCLO 4.12 
13.071 937 0.040 0.932 17.497 UNKNOWN 17.493 SM 1.18 
13.246 2677 0.046 0.932 17.596 UNKNOWN 17.595 SM 3.38 
Figure 9. GC chromatogram of fatty acid analysis of Streptomyces sp. SHP 1-2. 
3.2.2 Multilocus sequence analysis (MLSA) 
Based on MLSA analysis resulting from the concatenation of 5 house-keeping genes 
head to tail, it was determined that Streptomyces sp. SHP 1-2 and Streptomyces 
fumigatiscleroticus NRRL B-3856 T were very closely related with high significant 
bootstrap values or by the stability of the relationship when different phylogenetic 
algorithms are used, such as maximum-likelihood and neighbour-joining analyses 




















fumigatiscleroticus NRRL B-3856T was 0.058 (Table 18). Streptomyces sp. SHP 1-2 
showed to have MLSA distance more than 0.007 with all of the other related species. 
The similarities of 16S rRNA gene sequence between Streptomyces sp. SHP 1-2 and 












Figure 10. Menaquinones detected in Streptomyces sp. SHP 1-2. A: structure of 
menaquinone-9 (MK-9); B: Chromatogram from LC-MS of detected menaquinones; C: 










Figure 11. Polar lipid observed in Streptomyces sp. SHP 1-2. DPG: 
diphosphatidylglycerol; PE: phosphatidethanolamine; PI: phosphatidylinositol; PIM: 
phosphatidylinositol mannoside; GL: unknown glycolipid; PL: unknown phospholipid; 

















Figure 12. Neighbour-joining tree based on 16S rRNA gene sequences (1435 positions in 
the final dataset) showing relationships between strain SHP 1-2T and the type strains of 
closely related Streptomyces species. The evolutionary distances were determined using 
the Tamura-Nei method178. Asterisks indicate branches of the tree that were also found 
using the maximum-likelihood and maximum-parsimony tree-making algorithms. ML 
specify nodes that were also recovered using the maximum-likelihood. Numbers at the 
nodes are percentage bootstrap values based on a neighbour-joining analysis of 1,000 
replicates, only values above 50 % are shown. Bar 0.0050 substitutions per nucleotide 
position. 
3.2.3 G+C content and full genome sequencing 
The G+C content of Streptomyces sp. SHP 1-2 was found to be 73.37% based on 
HPLC analysis (Figure 14). Full genome analysis based on next-generation 
sequencing technique (NGS) exhibited that the genome size of the strain was 7,562765 
bp. 
3.2.4 Physiological and biochemical characteristic 
Streptomyces sp. SHP 1-2 could grow at 15-37oC (optimum 25-30oC) and pH 6-9 
(optimum pH 7). The strain was also able to grow in the presence of 7.5% NaCl, albeit 
the aerial mycelium was found only until 5% NaCl. Strain SHP 1-2 was sensitive to 
erythromycin (15 µg/disc), gentamycin 30 (µg/disc), tetracycline (30 µg/disc), 
vancomycin (30 µg/disc), and rifampicin (5 µg/disc). However it is resistant to 




Streptomyces sp. SHP 1-2 was only able to use glucose as their source of carbon. The 
results from API ZYM suggested that the strain possessed strong enzymatic activities 
for phosphatase alkaline, leucine arylamidase, alpha-glucosidase, and N-acetyl-beta-
glucoseamidase; however, it had weak activity for esterase (C4), esterase lipase (C8), 
lipase (C14), valine arylamidase, cysteine arylamidase, phosphatase acid, naphtol-AS-
BI-phosphohydrolase, beta-galactosidase, and beta-glucosidase. From API Coryne 
tests, it was found that the strain had positive results for alkaline phosphatase, alpha-
glucosidase, N-acetyl-beta-glucoseamidase, esculin (beta-glucosidase), and gelatinase 














Figure 13. Neighbour-joining tree based on concatenated partial sequences of the house-
keeping genes atpD, gyrB, recA, rpoB and trpB. The evolutionary distances were 
determined using the Tamura-Nei method178. There were totally 2528 positions in the 
final dataset. Asterisks indicate branches of the tree that were also found using the 
maximum-likelihood and maximum-parsimony tree-making algorithms. ML and MP 
specify nodes that were also recovered using the maximum-likelihood and maximum-
parsimony, respectively. Numbers at the nodes are percentage bootstrap values based 
on a neighbour-joining analysis of 1,000 replicates, only values above 50 % are shown. 








Table 18. MLSA distance between Streptomyces sp. SHP 1-2 and other related strains 
Compared strain MLSA distance  
Streptomyces misionensis NRRL B-3230 0.072 
Streptomyces paradoxus NRRL B-3457 0.094 
Streptomyces viridochromogenes NRRL B-1511 0.081 
Streptomyces lavenduligriseus NRRL ISP-5487 0.073 
Streptomyces malachitofuscus NRRL B-12273 0.083 
Streptomyces eurythermus NRRL ISP-5014 0.075 
Streptomyces phaeoluteichromatogenes NRRL B-5799 0.073 
Streptomyces nogalater NRRL ISP-5546 0.078 
Streptomyces calvus NRRL B-2399 0.079 
Streptomyces flaveolus NRRL B-1334 0.085 
Streptomyces leeuwenhoekii NRRL B-24963 0.072 
Streptomyces fumigatiscleroticus NRRL B-3856 0.058 




















Table 19. API ZYM and API Coryne test result for Streptomyces sp. SHP 1-2   
API ZYM Activity API Coryne Activity 
Alkaline phosphatase ++ Nitrate reduction - 
Butyrate esterase (C4) (+) Pyrazinamidase - 
Caprylate esterase lipase (C8) (+) Pyrrolidony arylamidase - 
Myristate lipase (C14) (+) Alkaline phosphatase + 
Leucine arylamidase ++ β-glucuronidase - 
Valine arylamidase (+) β-galactosidase - 
Cystine arylamidase (+) α-Glucosidase + 
Trypsin - N-acetyl-β-glucosamidase + 
α-Chymotrypsin - Esculin (β-glucosidase) + 
Acid phosphatase (+) Urease - 
Naphtol-AS-BI-
phosphohydrolase 
(+) Gelatine (hydrolysis) + 
α-Galactosidase - Glucose fermantation - 
β-Galactosidase (+) Ribose fermentation - 
β-Glucoronidase - Xylose fermentation - 
α-Glucosidase ++ Mannitol fermentation - 
β-Glucosidase (+) Maltose fermentation - 
N-acetyl-β-glucosaminidase ++ Lactose fermentation - 
α-Mannosidase - Sucrose fermentation - 
α-Fucosidase - Glycogen fermentation - 
++ more positive result; + positive result; (+) weakly positive result; - negative result. 
 
3.2.5 Phenotypic characteristic between Streptomyces sp. SHP 1-2 and its 
closest related strains 
To make more support for separation between species, some phenotypic properties of 
Streptomyces sp. SHP 1-2 was compared to the very close strains based on its 16S 
rDNA and MLSA result. Streptomyces malachitofuscus DSM 40332T, Streptomyces 
viridochromogenes DSM 40110 T and Streptomyces misionensis DSM 40306 T were 
used as they are very close based on their 16S rDNA. Streptomyces fumigatiscleroticus 
DSM 43154 T was employed because it is very close according to MLSA result (Table 






Table 20. Some phenotypic comparison between Streptomyces sp. SHP 1-2 and its closest 
related strains 
Characteristic 1 2 3 4 5 
ISP 2 - aerial mycelium Traffic grey 
B, signal 
white 
Sparse Grey Blue grey None 
ISP 6 - soluble pigment None None Brown Brown None 
ISP 7 - soluble pigment None Red Black None None 
Use of carbohydrate      
Glucose + - + + + 
Arabinose - + + + (+) 
Sucrose - - + - - 
Xylose - - - + ++ 
Inositol - - + + (+) 
Mannitol - + (+) + (+) 
Fructose - + + + (+) 
Rhamnose - + + - - 
Raffinose - + - - - 
API ZYM      
Phosphatase alcaline ++ ++ ++ ++ ++ 
Trypsin - (+) + + - 
Chymotrypsin - (+) + (+) (+) 
α-Glucosidase ++ + ++ - ++ 
N-acetyl-beta-
glucoseamidase 
++ - + 
++ ++ 
α-Mannosidase - ++ ++ ++ ++ 
API Coryne      
Nitrate reduction - + - - - 
Pyrrolidonyl arylamidase - - - - + 
β-Galactosidase - + - - + 
Esculin (beta glucosidase) + + - - + 
Gelatine(hydrolysis) + + + - + 
++ more positive result; + positive result; - negative result; (+) weakly positive result; 1: Strain 
SHP 1-2; 2: S. fumigatiscleroticus DSM 43154 T; 3: S. malachitofuscus DSM 40332; 4: S. 













Indolactam Variant 1 




Molecular weight: 317.39 
 
3.3 Compounds isolated from Streptomyces sp. SHP 1-2 and their biological 
activity 
This experiment was conducted together with Gian Primahana (Ph.D student in the 
working group “Microbial drugs” of the HZI, Braunschweig, Germany), Dr. Rizna T. 
Dewi (scientist from Research Center of Chemistry, LIPI, Indonesia), and Dr. Enge 
Sudarman (scientist in the working group “Microbial drugs” of the HZI, 
Braunschweig, Germany). There were six compounds isolated from Streptomyces sp. 
SHP 1-2. Two of them were new compounds (indolactam variant 1 and indolactam 
variant 2). Four known compounds were Lyngbyatoxin A, Cyclo(phenylalanylprolyl), 










Figure 15. Compounds isolated from Streptomyces sp. SHP 1-2. 
Piericidin A1 showed potent antimicrobial activity against Escherichia coli TolC, 
Chromobacterium violaceum, Bacillus subtilis, and Micrococcus luteus with the MIC 
values less than 5 µg/ml. Piericidin A1 also had activity in the inhibition of almost all 
tested mammalian cells. Besides, piericidin A1 was the only isolated compound that 
possessed antinematode activity. Indolactam variant 1 and indolactam variant 2 
showed no activity against all of the tested bacteria, fungi, and nematode. Indolactam 
variant 1 inhibited moderately the growth of KB-3-1 and PC-3 cells with IC50 8 and 
31 µg/ml, respectively. Indolactam variant 2 could inhibit reasonably KB-3-1, PC-3, 
and SK-OV-3 cell lines with the IC50 3.5, 18, and 25 µg/ml respectively. Lyngbyatoxin 
A showed antimicrobial activity against some Gram-positive bacteria Staphylococcus 




exhibited cytotoxic activity against all of eight mammalian cells; however, no activity 
was observed against nematode Caenorhabditis elegans (Table 21). 
Table 21. Biological activity of compounds isolated from strain SHP 1-2. 
Tested orgainsm 
Compound 
1 2 3 4 5 6 
Microbes MIC (µg/ml) 
Escherichia coli > 66.7 ND > 66.7 > 66.7 ND > 66.7 
Escherichia coli 
TolC 
2.32 ND > 66.7 > 66.7 ND > 66.7 
Chromobacterium 
violaceum 
1.16 ND > 66.7 > 66.7 ND > 66.7 
Pseudomonas 
aeruginosa 
> 66.7 ND > 66.7 > 66.7 ND > 66.7 
Staphylococcus 
aureus 
> 66.7 ND > 66.7 > 66.7 ND 4.75 
Bacillus subtilis 2.5 ND > 66.7 > 66.7 ND 2.38 
Micrococcus luteus 4.65 ND > 66.7 > 66.7 ND 4.75 
Mycobacterium 
smegmatis 
> 66.7 ND > 66.7 > 66.7 ND > 66.7 
Mucor hiemalis > 66.7 ND > 66.7 > 66.7 ND > 66.7 
Pichia anomala > 66.7 ND > 66.7 > 66.7 ND > 66.7 
Candida albicans > 66.7 ND > 66.7 > 66.7 ND > 66.7 
Mamalian cells IC50  (µg/ml) 
L-929 5.1 ND > 100 > 100 ND 4.1 
KB-3-1 0.57 x 
10-3 
ND 8 3.5 ND 2 
A-549 ND ND > 100 > 100 ND 0.45 x 10-3 
PC-3 0.33 x 
10-3 
ND 31 18 ND 1.7 
MCF-7 8.55 x 
10-3 
ND > 100 > 100 ND 3.4 
A-431 17 x 10-3 ND > 100 > 100 ND 2.3 
SK-OV-3 0.64 x 
10-3 
ND > 100 25 ND 5.5 
HUVEC 25 x 10-3 ND ND ND ND 1.9 
Nematode LC50 (µg/ml) 
Caenorhabditis 
elegans 
10.8 > 100 > 100 > 100 > 100 > 100 
1: Piericidin A1; 2: Indolactam V; 3: Indolactam variant 1; 4: Indolactam variant 2; 5: Cyclo 




3.4 Taxonomy study and extract analysis of strain MAE 1-11 
3.4.1 Morphology and melanin production 
Growth of isolate MAE 1-11 was well observed on ISP 2, ISP 3, ISP 4, ISP 5, ISP 6, 
ISP 7, SSM+T and SSM-T medium. The strain can also produce melanin in ISP 6 and 
SSM+T medium (Table 22). The morphology of the isolate MAE 1-11 in GYM and 
ISP 2 medium can be seen in Figure 16.  
Table 22. Growth and characteristics of strain MAE 1-11 grown on various agar media 
after incubation for 14 days at 30°C  
























Signal white None 
Peptone-yeast extract-
iron (ISP 6) 
Yellow olive; 
olive drab; sepia 
brown 
Signal white Chocolate brown; 
mahogany brown 
Tyrosine (ISP 7) Brown beige; 
maize yellow 





medium with tyrosine 
(SSM+T) 
Olive brown; clay 
brown 








3.4.2 16S rRNA gene analysis 
The almost complete 16S rRNA gene (1,498 nt) was analyzed by EzTaxon server 
(http://www. ezbiocloud.net/taxonomy)156 and the result suggested that isolate MAE 
1-11 was found to be closely related to the type strains of Kitasatospora albolonga 
NBRC 13465(T) (99.93%), Streptomyces cavourensis NBRC 13026T (99.86%), and 
Streptomyces bacillaris NBRC 13487T  (99.38%). In the phylogenetic tree based on 
the 16S rRNA gene sequences of strain MAE 1-11 and its closest type strains, the 




13026T, close to K. albolonga NBRC 13465T and Streptomyces araujoniae ASBV-1T 
by using Neighbour-Joining method161. However, the subclade consisting of strain 
MAE 1-11 and S. cavourensis NBRC 13026T were not founded in the tree constructed 




















Figure 17. Neighbour-joining phylogenetic tree based on nearly complete 16S rRNA gene 
sequences between strain MAE 1-11 and its closely related neighbours. The evolutionary 
history was inferred using the Neighbor-Joining method161. The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (1000 
replicates) are shown next to the branches162. The evolutionary distances were computed 
using the Kimura 2-parameter method175. There were a total of 1426 positions in the 
final dataset. Evolutionary analyses were conducted in MEGA X158. Asterisks and filled 
circles indicate branches of the tree that were also found using the maximum-likelihood 




3.4.3 Physiological and biochemical characteristic 
Strain MAE 1-11 was able to grow in the presence of 10% NaCl; however, the aerial 
mycelium was found only until 5% NaCl. The strain could be cultivated by using 
glucose, xylose, mannitol, and fructose (Table 23). 
Table 23. Some physiology properties of strain MAE 1-11 
Characteristic Observation  Observation 
Use of carbohydrate  Use of carbohydrate  
Glucose + Mannitol + 
Arabinose - Fructose + 
Sucrose (+) Rhamnose (+) 
Xylose + Raffinose (+) 











Esterase (C4) + α-Galactosidase - 
Esterase Lipase (C8) + β-Galactosidase (+) 
Lipase (C14) ++ β-Glucuronidase - 
Leucin arylamidase ++ α-Glucosidase ++ 





Trypsin ++ α-Mannosidase - 
Chymotrypsin ++ α-Fucosidase - 
Phosphatase acid +   
API Coryne  API Coryne  
Nitrate reduction + Gelatine (hydrolysis) + 
Pyraziamidase - Glucose fermentation - 
Pyrrolidonyl arylamidase - Ribose fermentation - 
Alkaline phosphatase + Xylose fermentation - 
β-Glucuronidase - Mannitol fermentation - 
β-Galactosidase + Maltose fermentation - 









Esculin (beta glucosidase) + Glycogen fermentation - 
Urease +   
++ more positive result; + positive result; (+) weakly positive result; - negative result.  
 
3.4.4 Raw extract analysis 
The raw extract derived from SYP medium was analyzed by LC-HRMS (MAXIS) and 
the chromatogram result can be seen in Figure 18. It was found that the peak in the 
retention time between 14.74-14.99 min (compound no.1) has the antiviral activity 
against HCV. From the mass analysis, it was known that the mass of the compound is 
604.3978 Da. Using the data of the compound mass and the UV spectrum as well as 
submitting it in the Dictionary Natural Product, it was then figured out that compound 
no. 1 is Bafilomycin D. In addition, by comparing with the pure Bafilomycin D, it was 
also revealed that the compound no. 1 is Bafilomycin D (Figure 19).  
3.5 Taxonomic study of strain 196526CR 
3.5.1 Morphology and melanin production  
Strain 196526CR could be grown well on ISP 2, ISP 5, ISP 6, ISP 7, SSM+T and 
SSM-T medium. Growth in ISP 3 was sparse and no growth was observed in ISP 4. 
The strain produced no melanin in the melanin production medium (Table 24). The 
morphology of the isolate 196526CR in GYM and ISP 2 medium can be seen in Figure 
20.  
3.5.2 16S rRNA gene analysis  
The almost complete 16S rRNA gene (1,458 nt) was used in the EzTaxon analysis 
(http://www. ezbiocloud.net/taxonomy)156. It was found that strain 196526CR was 
close to the type strains of Amycolatopsis thermalba SF45T (98.85%), Amycolatopsis 
deserti GY024T (98.84%), Amycolatopsis methanolica 239T (98.75%) and 
Amycolatopsis endophytica KLBMP 1221T (98.75%). In a phylogenetic tree, the 
isolate 196526CR formed a distinct subclade and clustered with Amycolatopsis deserti 
GY024T, close to Amycolatopsis endophytica KLBMP 1221T and Amycolatopsis 
thermophile GY088T by using the neighbour-Joining method. The subclade consisting 
of strain 196526CR and Amycolatopsis deserti GY024T were also founded in the tree 




























Figure 18. LC-HRMS analysis result of raw extract of strain MAE 1-11 produced by 
SYP medium. A: Chromatogram of raw extract detected by 200-600 nm; B: UV 
Spectrum of compound no. 1 from the chromatogram; C: Mass spectrum of compound 
































Figure 19. LC-HRMS analysis result of Bafilomycin D. A: Structure molecule of 
bafilomycin D and its chromatogram detected by 200-600 nm and the; B: UV Spectrum 







Table 24. Growth and characteristics of isolate 196526CR grown on various agar media 
after incubation for 14 days at 30°C 









extract (ISP 2) 
Good Signal yellow Pure white None 
Oatmeal (ISP 3) Sparse Sand yellow Cream None 
Inorganic salt- 
starch (ISP 4) 
None None None None 
Glycerol-
asparagine (ISP 5) 
Good Sand yellow Pure white None 
Peptone-yeast 
extract-iron (ISP 6) 
Good Honey yellow None None 






































Figure 21. Neighbour-joining phylogenetic tree based on nearly complete 16S rRNA gene 
sequences between strain 196526CR and its closely related neighbours. The evolutionary 
history was inferred using the Neighbor-Joining method161. The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (1000 
replicates) are shown next to the branches162. The evolutionary distances were computed 
using the Kimura 2-parameter method175. There were a total of 1344 positions in the 
final dataset. Evolutionary analyses were conducted in MEGA X158. Asterisks and filled 
circles indicate branches of the tree that were also found using the maximum-likelihood 
and maximum-parsimony tree-making algorithms, respctively.  
 
3.5.3 Physiological and biochemical characteristic 
Strain 196526CR grew in the presence of 5% NaCl. The strain could also grow well 
by using glucose and fructose. Weak growth was detected on the medium containing 
arabinose, xylose, mannitol, and rhamnose. The results from API ZYM suggested that 
the strain possessed substantial enzymatic activities for β-Glucosidase and N-acetyl-
beta-glucoseamidase. It also had good activities for phosphatase alkaline, phosphatase 
acid, urease, and gelatinase (Table 25).  
3.5.4 Secondary metabolites produced by strain 196526CR 
In 5294HG-S medium, strain 196526CR produced coproporphyrin III, zinc 
coproporphyrin III, and nitrosoxacin C (Figure 22). Coproporphyrin III and zinc 
coproporphyrin III was detected both in the biomass and in the XAD extract, while 




inhibit Bacillus substilis (MIC = 33.4 µg/ml) and Staphylococcus aureus (MIC = 33.4 
µg/ml).     
Table 25. Some physiology properties of strain 196526CR  
Characteristic Observation  Observation 
Use of carbohydrate  Use of carbohydrate  
Glucose + Mannitol (+) 
Arabinose (+) Fructose + 
Sucrose - Rhamnose (+) 
Xylose (+) Raffinose - 
Inositol - Cellulose - 
NaCl tolerance 5%   





Esterase (C4) - α-Galactosidase - 
Esterase Lipase (C8) (+) β-Galactosidase (+) 
Lipase (C14) (+) β-Glucuronidase - 
Leucin arylamidase ++ α-Glucosidase - 





Trypsin (+) α-Mannosidase (+) 
Chymotrypsin - α-Fucosidase - 
Phosphatase acid +   
API Coryne  API Coryne  
Nitrate reduction - Gelatine(hydrolysis) + 






Alkaline phosphatase + Xylose fermentation - 
β-Glucuronidase - Mannitol fermentation - 
β-Galactosidase - Maltose fermentation - 











Urease +   

























UV and MS spectrum 
Zn-Coproporphyrin III 

















































Figure 24. Chromatogram, UV and MS spectrum of Nitrosoxacin C found in the biomass 
extract of strain 196526CR. 
3.6 Taxonomic study of Streptomyces sp. ASO4wet 
3.6.1 Morphology and physiology 
After incubation for four weeks, strain ASO4wet formed aerial mycelium with no 
spore was detected on ISP3 agar (Figure 25). From the physiological study, it was 
found that strain ASO4wetT grew at 15-37oC (optimum at 25-30oC) and pH 6-9 
(optimum at pH 7). Antibiotic susceptibility test suggested that isolate ASO4wet was 
sensitive to ampicillin (10 µg/disc), erythromycin (15 µg/disc), gentamycin 30 
(µg/disc), penicillin G (6 µg/disc), tetracycline (30 µg/disc), vancomycin (30 µg/disc), 












Figure 25. Scanning electron micrographs of aerial mycelium with no spore detected of 
strain ASO4wetT after incubation on ISP 3 agar for 4 weeks at 30°C. 
3.6.2 Chemotaxonomy  
The cell-wall of isolate ASO4wetT contained LL-diaminopimelic acid. Glucose and 
xylose were detected in its whole-cell hydrolysates (Figure 26). The identified fatty 
acids in strain ASO4wetT were iso-C16:0 (35.01%), anteiso-C15:0 (21.97%), iso-
C15:0 (13.75%), anteiso-C17:0 (8.80%), and iso-C14:0 (6.31%) (Figure 27). 
Menaquinone MK-9(H8) and MK-9(H6) were detected in a ratio of 12:1 (Figure 28). 
The polar lipid compositions were identified as diphosphatidylglycerol, 
phosphatidylglycerol, phosphatidylethanolamine, phosphatidyl-N-methyl-
ethanolamine, phosphatidylinositol mannoside, and four unidentified polar lipids 
(Figure 29).   
3.6.3 16S rRNA gene analysis 
By using BLAST or basic local alignment search tool from NCBI server (http:// 
www.ncbi.nlm.nih.gov/BLAST/)179, it was founded that isolate ASO4wetT belongs to 
the genus Streptomyces. The strain was closely related to Streptomyces karpasiensis 
K413T (98.87%), Streptomyces glycovorans YIM M 10366T (98.38%), and 
Streptomyces abyssalis M 10400T (97.53%). It was located in the clade together with 
Streptomyces karpasiensis K413T and Streptomyces glycovorans YIM M 10366T that 
was supported by 89% bootstrap value in the neighbour-joining tree based on the 16S 
rRNA gene sequence (Figure 30). The relationship between these strains in the 
phylogenetic tree was also retrieved by using maximum-likelihood and maximum-




3.6.4 Full genome analysis 
The draft genome of strain ASO4wetT was derived from PacBio-Sequencing. There 
was in total 7,377,472 bp was measured and the genome coverage was 117x. The 
genome was assessed by using Illumina MiSeq data and it encodes for about 6,500 













Figure 26. TLC chromatogram of whole-cell sugar analysis (left) and analysis amino acid 
of the cell wall (right) of isolate ASO4wet. S1: Standard 1; S2: Standard 2; X: Xylose; 
A: Arabinose; Gal: Galactose; DPM: Diaminopimelic acid standard; LL-: LL- 
























RFact ECL Peak Name Percent 
1.629 3.696E+8 0.026 ---- 7.010 SOLVENT PEAK ---- 
2.536 137 0.023 ---- 8.810  ---- 
4.385 334 0.027 1.064 11.608 12:0 ISO 0.08 
5.448 830 0.036 1.020 12.612 13:0 ISO 0.20 
5.551 906 0.033 1.017 12.701 13:0 ANTEISO 0.22 
6.738 26965 0.035 0.986 13.617 14:0 ISO 6.31 
7.259 863 0.037 0.976 13.998 14:0 0.20 
8.219 60288 0.038 0.962 14.622 15:0 ISO 13.75 
8.360 96480 0.039 0.960 14.714 15:0 ANTEISO 21.97 
8.581 628 0.035 0.958 14.857 15:1 B 0.14 
8.799 2495 0.040 0.955 14.999 15:0 0.56 
9.565 21520 0.042 0.948 15.459 16:1 ISO H 4.84 
9.847 156126 0.042 0.946 15.628 16:0 ISO 35.01 
10.162 1862 0.040 0.943 15.817 16:1 CIS 9 0.42 
10.463 9394 0.043 0.941 15.998 16:0 2.10 
11.187 933 0.042 0.937 16.417 16:0 9? METHYL 0.21 
11.368 4876 0.044 0.937 16.521 17:1 ANTEISO C 1.08 
11.556 14143 0.043 0.936 16.629 17:0 ISO 3.14 
11.716 39661 0.045 0.935 16.722 17:0 ANTEISO 8.80 
12.006 1619 0.047 0.934 16.889 17:0 CYCLO 0.36 
12.194 847 0.044 0.934 16.998 17:0 0.19 
12.456 956 0.046 0.933 17.147 16:0 ISO 3OH 0.21 
13.310 1004 0.041 0.932 17.632 18:0 ISO 0.22 

























Figure 28. Menaquinones detected in isolate ASO4wet. A: Chromatogram from LC-MS 
of detected menaquinones; B: structure of menaquinone-9 (MK-9); C: UV Spectrum of 













Figure 29. Polar lipid observed in strain ASO4wet. DPG: diphosphatidylglycerol; PE: 
phosphatidethanolamine; PL: unknown phospholipid; GL1-3: unknown glycolipid; 



















Figure 30. Neighbour-joining tree based on 16S rRNA gene sequences (1408 positions in 
the final dataset) showing relationships between Streptomyces sp. ASO4wetT and its 
closely related Streptomyces species. The evolutionary distances were determined by 
using the Kimura 2-parameter method175. Asterisks mean branches of the tree that were 
also found using the maximum-likelihood and maximum-parsimony tree-making 
algorithms. ML and MP specify nodes that were also recovered using the maximum-
likelihood and maximum-parsimony respectively. Numbers at the nodes are percentage 
bootstrap values based on a neighbour-joining analysis of 1,000 replicates, only values 







4.1 Isolated Actinobacteria and their bioactivity 
In the isolation of Actinobacteria, the soil samples were treated by heating at 60°C for 
30 minutes before they were applied to the selection medium. Many vegetative 
bacterial cells are killed at 60°C. It is known that many vegetative yeast cells are more 
heat-sensitive than the vegetative bacterial cells and it is also previously reported that 
typically Gram-positive bacteria are more heat resistant than Gram-negative 
bacteria180. Some Actinobacteria living in soil, such as Actinomyces, Streptomyces, 
and Micromonospora form spores that can resist heat stress. Streptomyces, for 
example, are able to produce numerous hydrophobic spores that are moderately dense 
coat, contain small protective molecules like some group of sugars (trehalose), and 
consist of heat shock proteins181.  
The selection medium (5336 medium) for Actinobacteria isolation contains starch and 
casein. The combination of starch as the carbon source and casein as the nitrogen 
source was reported previously as one of the best media that permits good growth for 
Streptomyces. Moreover, it is also known that most of Streptomyces strains can use 
starch as the carbon source182. The medium also comprises magnesium sulfate 
(MgSO4), which is essential for the cell division of the bacteria. Magnesium ion is 
more needed for Gram-positive bacteria than for Gram-negative bacteria. This 
probably because Gram-positive bacteria incorporate the magnesium ion into the 
complex structure of their cell wall183.  
Nalidixic acid, an antibacterial compound, is also one of the components in the 
selection medium. It inhibits DNA replication in some bacteria, such as Escherichia 
coli and Bacillus substilis184. It is known as a selective, immediate, and reversible 
inhibitor of bacterial DNA synthesis185. The other antimicrobial compound used in the 
selection medium is cycloheximide. Cycloheximide is a glutarimide derivative that 
has property as an antifungal agent by inhibiting protein synthesis. The compound 
binds the ribosome and blocks the elongation phase of translation process186,187. Some 
studies have previously reported the usage of these antimicrobial agents in the 
selection media for some Actinobacteria isolation188,189.  
In this study, plenty of Actinobacteria were isolated by using the preheated method 
and 5336 medium. The contamination from fungi and other bacteria could also be 





Actinobacteria in this investigation belongs to Streptomyces. About 70% of the 
characterized strains were identified as Streptomyces and from the identified 
Streptomyces, only 27% of them had less than 99.50% similarity from the type strains 
based on 16S rRNA gene analysis. One of those is isolate SHP 1-2 that had 99.03% 
similarity to Streptomyces viridochromogenes NBRC 3113T. The extract produced by 
strain SHP 1-2 from 5294 medium could inhibit moderately the growth of 
Staphylococcus aureus and strongly inhibit the growth of Bacillus 
substilis and Micrococcus luteus.  
For other strains that were identified closely to non-Streptomyces type strains 
according to the 16S rRNA analysis, there are 24% of them, which had less than 99.5% 
similarity from the type strain. One of the isolated non-Streptomyces strain is isolate 
196526CR, which had 98.85% similarity to Amycolatopsis thermalba SF45T 
(98.85%). It produced an extract from 5294 medium that could inhibit, although 
moderately, the growth of Bacillus subtilis, Staphylococcus aureus, Mucor 
hiemalis, and Candida albicans. From the isolated strains that can yield extracts with 
moderate and strong activity against some tested microbes, almost 70% of them 
are Streptomyces strains.   
Ten isolated strains showed strong activity against hepatitis C virus (HCV). Three of 
them were closely related to Kitasatopora species according to the result from 
EzBioCloud server (https://www.ezbiocloud.net)156. These strains are isolate DHE 2-1, 
MAE 1-11, and C190221. Kitasatospora and Streptomyces are very closely related 
because both of them belong to the same family Streptomycetaceae. They also have a 
similar lifestyle and morphology. In the capability of producing bioactive 
compounds, Kitasatopora could also be equivalent to Streptomyces. The difference 
between these two genera is on their cell-wall peptidoglycan composition. The cell-
wall peptidoglycan of Streptomyces comprises LL-diaminopimelic acid (DAP), 
whereas Kitasatospora contains not only LL-diaminopimelic acid (LL-DAP) but also 
meso-DAP190.  
4.2 Description of strain SHP 1-2 and its secondary metabolites 
Strain SHP 1-2 was isolated from soil collected in Enggano Island, Indonesia. The 
isolate has a broadly branched substrate mycelium that bears aerial hyphae which 
develop into spiral chains of smooth-surfaced spores on ISP 3 agar medium. It is a 




analysis suggested that isolate SHP 1-2 is close related to Streptomyces species. It has 
high G+C content in its genomic DNA. The morphologic and chemotaxonomic 
characteristics of strain SHP 1-2 have corresponding profiles to some 
other Streptomyces species that have been previously reported 191–193. Therefore, it is 
determined that strain SHP 1-2 belongs to Streptomyces species. 
In the phenotypic characteristic, many differences are found between strain SHP 1-2 
and the closest relative strains based on 16S rRNA gene sequence, i.e., Streptomyces 
malachitofuscus DSM 40332T (99.03%), Streptomyces viridochromogenes DSM 
40110T (99.03%), and Streptomyces misionensis DSM 40306T (98.96%), as well as 
the closest one from the MLSA distance (Streptomyces fumigatiscleroticus DSM 
43154T, MLSA distance: 0.058). The significant difference is in the basis of single 
carbon source usage, as for strain SHP 1-2, it can only use glucose, while the others 
are able to use several of sole carbon sources. Furthermore, based on the enzymatic 
system, strain SHP 1-2 shows a substantial distinction with the others. The 
chymotrypsin activity was not detected in strain SHP 1-2, while in the others, the 
chymotrypsin activities are observed. It can be inferred; therefore, that strain SHP 1-
2, in the phenotypic features, is different from the compared type strains.    
Recently, however, there are some problems to delineate Streptomyces strains. This 
because of the vast amounts of isolates and insufficiently determined species, the weak 
resolution of 16S rRNA gene sequence as the phylogenetic standard, complexities in 
comparing essential phenotypic features between the strains, and inconvenience of 
DNA–DNA hybridization (DDH) and DNA fingerprinting for rapid analysis. 
Multilocus sequence analysis (MLSA) has been used recently in microbial systematic. 
MLSA has been recently used for delineation of Streptomyces species because of its 
robustness in the molecular method130.  
By using five house-keeping genes, i.e., atpD, gyrB, recA, rpoB and trpB in MLSA 
analysis, it was found that strain SHP 1-2 showed to have MLSA distance more than 
0.007 with all of the other related species. The MLSA distance of 0.007 is equivalent 
to 70 % DNA–DNA homology130. The MLSA distance that is more than 0.007 means 
that the strain can be separated with the other compared strains. After studying 
polyphasic taxonomy, that includes the genotypic and phenotypic comparison between 
strain SHP 1-2 and the close strains, it can be concluded that the strain SHP 1-2 is a 





Piericidin A1 is the most active compound produced by strain SHP 1-2. This 
compound is also produced by other Streptomyces species such as Streptomyces 
mobaraensis and Streptomyces pactum194. The mechanism of the activity against 
some tested organisms is suggested due to its ability to inhibit mitochondrial and 
bacterial NADH-ubiquinone oxidoreductases195. It was also previously reported that 
the compound possesses the antibacterial activity against Gram-negative 
bacteria  Chromobacterium violaceum CV026 by inhibiting the quorum-sensing 
mechanism196. 
Two new molecules that were isolated from strain SHP 1-2 are indolactam derivatives. 
These compounds have a moderate activity to inhibit the proliferation of KB-3-1 and 
PC-3 cells lines. As for indolactam variant II, it also has modest activity against SK-
OV-3 cell line. The other indolactam structure, indolactam V, was also isolated from 
strain SHP 1-2. It has been reported previously that indolactam V has numerous 
biological activities. It can stimulate protein kinase C (PKC), generate pancreatic 
progenitor cells from human embryonic stem cells (hESCs), and induce the Epstein-
Barr virus early antigen (EBV-EA) of Raji cells (B lymphocyte)197–199. This compound 
was previously also isolated from Streptomyces blastmyceticum NA3417 and known 
as a biosynthetic intermediate of teleocidins, which are identified as influential skin 
tumor promoters200.  
Two other compounds produced by strain SHP 1-2 are cyclo(phenylalanyl-prolyl) and 
lyngbyatoxin A. Cyclo(phenylalanyl-prolyl) is diketopiperazine molecule that was 
also isolated previously from Streptomyces sp. (NPS008187)201. The other study 
suggested that cyclo(phenylalanyl-prolyl) could be produced by Lactobacillus 
plantarum strain (MiLAB 393). The compound was also reported having biological 
activity property as antifungal agent202. As for lyngbyatoxin A, this compound was 
first reported in the previous study to be found in marine cyanobacterium Moorea 
producens (formerly Lyngbya majuscula). It is the causative compound of seaweed 
dermatitis. It has a highly inflammatory effect, vigorous tumor-promoting activity and 
capability to stimulate protein kinase C isozymes. The compound was determined to 
be the same as teleocidin A-1, which was isolated from Streptomyces mediocidicus203.  
4.3 Description of strain MAE 1-11 and its secondary metabolites 
The calculation from EzBioCloud server (https://www.ezbiocloud.net)156 using 16S 




strain Kitasatospora albolonga NBRC 13465T (99.93%). The phylogenetic tree 
analysis result, however, indicated that strain MAE-11 was closer to Streptomyces 
cavourensis NBRC 13026T than to K. albolonga NBRC 13465T according to the 
neighbour-joining algorithm. The clade was also supported by a relatively high 
percentage of bootstrap value.   
Kitasatospora is the genus of Actinobacteria, which was firstly proposed in 1982 and 
the name itself refers to Kitasato, who was a Japanese bacteriologist98. Kitasatospora 
and Streptomyces are very closely related in the taxonomy as both of them are in the 
same family Streptomycetaceae and also look similar in their morphology. The thing 
that makes them different is the cell-wall composition. Streptomyces contains LL-
diaminopimelic acid and no meso-diaminopimelic acid, whereas Kitasatopora has 
both of the LL- and meso-diaminopimelic acid204. The other thing which different is 
that Kitasatopora has galactose as the diagnostic sugar, while Streptomyces has no 
diagnostic sugar125.  
Strain MAE 1-11 was isolated from soil collected in the mangrove area of Enggano 
Island, Indonesia. It is a halotolerant and melanin producer bacterium. Strain MAE 1-
11 can be distinguished from K. albolonga NRRL B-3604T (= NBRC 13465T) on the 
basis of the enzymatic system. K. albolonga NRRL B-3604T (= NBRC 13465T) does 
not have activity for phosphatase alkaline, esterase (C4), alpha-chymotrypsin, and 
alpha-glucosidase, while strain MAE 1-11 have all these enzymes205,206. Strain MAE 
1-11 is also different from S. cavourensis NBRC 13026T according to the enzymatic 
activity. Some enzymes were not detected in S. cavourensis NBRC 13026T, such as 
esterase (C8), trypsin, phosphatase acid, naphtol-AS-BI-phosphohydrolase, and beta-
galactosidase206, whereas isolate MAE 1-11 equipped with these enzymes.       
The primary compound produced by strain MAE 1-11 is bafilomycin D. The 
compound has antiviral activity against HCV. Bafilomycin D is a 16-membered ring 
macrolide antibiotic that possesses activity in the inhibition of V- and P-ATPases, 
although it is not as strong as bafilomycin A1. V-ATPases are vacuolar-type, proton-
translocating ATPases (V-ATPases), while P-ATPases are ATPases with 
phosphorylated states (P-ATPases). Both of them can be found in animal and plant 
cells, as well as in yeast, fungi, and bacteria207. Bafilomycin D was also previously 





Streptomyces albolongus (novel name is Kitasatospora albolonga) strain YIM 
101047208–210.  
The mechanism of antiviral bafilomycin D against HCV may be similar to how 
bafilomycin A1 can inhibit influenza A virus (IAV) replication. Bafilomycin A1 at 
relatively high concentration (≥10 nM) was reported that it could inhibit V-ATPase 
and decrease endosome acidification as well as lysosome number; consequently, it 
diminished IAV replication. However, it could also trigger cytotoxicity for the host 
cell. Interestingly, at a shallow concentration (0.1 nM), this molecule was still able to 
inhibit the replication, and the release of IAV albeit this amount of bafilomycin A1 is 
neither causing reduction of lysosome number nor toxic to the host cell211.  
4.4 Description of strain 196526CR and its secondary metabolites 
The 16S rRNA gene analysis, according to the result from EzBioCloud server 
(https://www.ezbiocloud.net)156, suggested that strain 196526CR was very close to the 
type strain Amycolatopsis thermalba SF45T (98.85%), however, based on the 
constructed phylogenetic tree, Amycolatopsis deserti GY024T was the closest strain to 
strain 196526CR. The clade formed in the phylogenetic tree between strain 196526CR 
and A. deserti GY024T was found both with the neighbour-joining and maximum-
likelihood method, although in neighbor-joining method, this clade was only 
supported by less than 50% of bootstrap values. 
Amycolatopsis is one of the genera in Actinobacteria and belongs to the family 
Pseudonocardiaceae212. Until now, the genus Amycolatopsis includes already 76 
published species (http://www.bacterio.net/amycolatopsis.html). Amycolatopsis can 
be distinguished from the other genera in the family Pseudonocardiaceae by using 
genotypic and phenotypic assessment. It has no sporangia; no motile spores; the 
diagnostic sugars are arabinose and galactose; the phospholipid system contains PE 
(phosphatidylethanolamine), DPG (diphosphatidylglycerol), PG (phosphatidyl-
glycerol), and PI (phosphatidylinositol; and the predominant menaquinone is MK-
9(H4)213. The spores in Amycolatopis can be found both in aerial and substrate hyphae. 
The spores in aerial hyphae are formed in chains, the genus also has fragmented 
substrate hyphae214 and contains meso-diaminopimelic acid in its cell-wall 
structure212. The genus-specific primers for Amycolatopsis were also constructed in 




Some antibiotics are produced by genus Amycolatopsis. Species Amycolatopsis 
orientalis is the producer of vancomycin, which is a strong glycopeptide antibiotic that 
has activity against methicillin-resistant Staphylococcus aureus (MRSA) infections216. 
Balhimycin, which is categorized to the vancomycin class of glycopeptide antibiotic, 
is produced by Amycolatopsis Amycolatopsis balhimycina. Balhimycin was found to 
be correspondingly strong as vancomycin against MRSA strains and more powerful 
than vancomycin, specifically against Clostridium strains217. Amycolatopsis 
mediterranei is well-known as a producer of Rifamycin B, which is used for the 
treatment of tuberculosis and other diseases caused by Mycobacterium. Rifamycin B 
belongs to the ansamycin family, which is characterized by a macrocyclic structure 
containing aromatic moiety bridged by an aliphatic ansa chain218,219.  
Strain 196526CR was isolated from soil in Bali, Indonesia. The strain is a halotolerant 
and non-melanin producing bacterium. The isolate can grow well by using glucose 
and fructose as a single carbon source, however, there was no alpha-glucosidase 
activity detected in this strain. Alpha-glucosidase is one of the essential enzymes in 
starch hydrolysis to produce glucose220. This may be the reason why the strain can not 
grow in ISP 4 medium, which contains only starch as the single source of carbon. 
Not like strain 196526CR, one of the close strains, A. deserti GY024T, have no 
enzymatic activity in beta-glucosidase. Another close type strain, A. thermalba SF45T 
were found not having N-acetyl-beta-glucoseamidase and acid phosphatase221, 
whereas, for the strain 196526CR, these enzymes are produced. This finding may 
suggest that strain 196526CR can probably be distinguished from A. deserti GY024T 
and A. thermalba SF45T based on the enzymatic system.     
Some compounds that are produced by strain 196526CR are coproporphyrin III, zinc 
coproporphyrin III, and nitrosoxacin C. Coproporphyrin III is a tetrapyrrole moiety 
and is the primary intermediate of heme biosynthesis in Amycolatopsis and other 
Actinobacteria. Heme is very important in the numerous biological process. It 
functions as a prosthetic group for various proteins, such as cytochromes, globins, 
catalases, peroxidases, and transporters. These proteins are essential in respiration, 
photosynthesis, metabolism, and transport of oxygen in organisms222,223. 
Zinc coproporphyrin III is the derivative of coproporphyrin III which is bound to zinc 





for zinc than other metals224. The compound was also found in Streptomyces sp. 
AC8007 and has some biological activities, such as a histamine-release inhibitor and 
a potent photosensitizer for controlling tumor growth in photodynamic cancer 
therapy225.  
Nitrosoxacin C was isolated by using bioassay-guided isolation against 
Staphylococcus aureus since the molecule was difficult to be detected by the UV 
detector. The MIC results suggest that Nitrosoxacin C has moderate antimicrobial 
activity against Staphylococcus aureus and Bacillus substilis. It is not known 
previously that Nitrosoxacin C has antibacterial activity against these bacteria. The 
previous study reported that Nitrosoxacin C was isolated from Streptomyces sp. 
AA4091 and it is known to have the activity as a 5-lipoxygenase inhibitor. The 
possible mechanism of 5-lipoxygenase inhibitory activity is because of its chelating 
activity226. 5-lipoxygenase inhibitors are used in the treatment of inflammatory bowel 
disease (IBD)227.         
4.5 Description of strain ASO4wet 
Strain ASO4wet was isolated from the sponge in a deep-sea collected from the North 
Atlantic Ocean.  Some of the characterizations of this strain were conducted previously 
by Landwehr147. These include 16S rDNA analysis, morphology and melanin 
production, some physiological studies, MALDI-TOF analysis by using ribosomal 
protein, DNA-DNA hybridization, and ribotyping analysis with some closely related 
strains. This recent study reports the other characteristics such as morphology by 
scanning electron microscopy (SEM), some physiology studies, chemotaxonomy 
assessment, phylogenetic tree construction based on 16S rRNA gene, and full genome 
sequencing for determining the size of the genome as well as the G+C content.  
Strain ASO4wet is an aerobic and Gram-positive bacterium that forms branched 
substrate mycelium with the aerial hyphae that can be seen in ISP3 and ISP7 agar 
medium. The strain grows well on ISP2, ISP3, ISP4, and ISP5 after two weeks 
incubation at 30°C. The enzymatic system comprises esterase (C4), trypsin, 
chymotrypsin, β-galactosidase, and α-glucosidase. The NaCl tolerance of this strain is 
0-10% (w/v) NaCl. The strain can grow with glucose, arabinose, sucrose, xylose, 




Spores were not observed in ISP3 even after four weeks incubation at 30°C. The 
optimum growth was detected at 25–30°C and at pH 7. From the 16S rRNA and 
chemotaxonomy analysis results as well as the high G+C content in its genomic DNA, 
it is determined that strain ASO4wet is a member of the genus Streptomyces. Strain 
ASO4wetT formed a stable subclade with Streptomyces karpasiensis K413T with high 
bootstrap value and adjacent to Streptomyces glycovorans YIM M 10366T. The 
position in the phylogenetic tree between these Streptomyces strains was also 
confirmed by the maximum-likelihood and maximum-parsimony methods.  
Strain ASO4wet can be separated from its closest strains based on the enzymatic 
system such as lipase (C14), beta-galactosidase, beta-glucosidase, the use of single 
carbon, MALDI-TOF, and ribotyping analysis. Furthernore, the DNA-DNA 
hybridization results with the closest Streptomyces type strains are lower than 70%147. 











Hundreds of Actinobacteria were successfully isolated from Indonesian source 
samples. However, due to the limitation of time allocation, only around half of them 
were characterized. The study was focused on strain SHP 1-2, MAE 1-11, and 
19626CR due to its ability to produce active extracts against either some microbes or 
hepatitis C virus (HCV). Another strain that was used in this study was strain 
ASO4wet that was isolated previously from deep-sea in the North Atlantic Ocean. 
Strain SHP 1-2 was known to produce two novel indolactam derivatives. It was also 
suggested that strain SHP 1-2 is the novel species in the genus Streptomyces. 
Bafilomycin D, which was produced by strain MAE -11, was revealed to have antiviral 
properties against HCV. This strain is closely related to Kitasatopora and 
Streptomyces species. Strain 196526CR, which was characterized as Amycolatopsis 
species, generated nitrosoxacin C that has antimicrobial property. The antimicrobial 
activity of nitrosoxacin C was firstly reported in this study. A chemotaxonomic study 
of strain ASO4wet gave supporting data that this strain belongs to the genus 
Streptomyces. 
Streptomyces species can typically be detected by their aerial mycelium formation. 
However, some non-Streptomyces genera such as Kitasatospora, Amycolatopsis, and 
Pseudonocardiopsis also have similar aerial mycelium as Streptomyces. The 
chemotaxonomic study, especially for amino acid of cell-wall analysis, can distinguish 
between Streptomyces and non-Streptomyces species based on the present of LL-
diaminopimelic acid and its isomer. The identification based on 16S rRNA sequence 
further is needed to clarify which type strain the isolates are close to. Around half of 
the isolates were not studied yet either for taxonomic characterization or for metabolite 
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Table S 1. List of Actinobacteria strains isolated from Indonesian samples  
No. Strain Samples location No. Strain Samples location 
1 4421 Beach, Bali 99 196831CR Botanical Garden, Bali 
2 4422 Beach, Bali 100 196833CR Botanical Garden, Bali 
3 4423 Beach, Bali 101 196921CR Botanical Garden, Bali 
4 4431 Beach, Bali 102 196932CR Botanical Garden, Bali 
5 4433 Beach, Bali 103 197011CR Botanical Garden, Bali 
6 4435 Beach, Bali 104 197012CR Botanical Garden, Bali 
7 5931 Lava beach, Bali 105 197013CR Botanical Garden, Bali 
8 19821 Botanical Garden, 
Bogor, West Java 
106 197014CR Botanical Garden, Bali 
9 19823 Botanical Garden, 
Bogor, West Java 
107 197017CR Botanical Garden, Bali 
10 19824 Botanical Garden, 
Bogor, West Java 
108 197019CR Botanical Garden, Bali 
11 190221 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
109 197212CR Botanical Garden, Bali 
12 190224 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
110 1982-1 Botanical Garden, 
Bogor, West Java 
13 190225 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
111 1982-3 Botanical Garden, 
Bogor, West Java 






Bogor, West Java 
15 190232 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
113 1982-4 Botanical Garden, 
Bogor, West Java 
16 190233 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
114 198311CR Botanical Garden, 
Bogor, West Java 
17 190234 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
115 198331CR Botanical Garden, 
Bogor, West Java 
18 190235 Forest low altitude, 
Kendari, Southeast 
Sulawesi 
116 198332CR Botanical Garden, 
Bogor, West Java 
19 190401 Mangrove, Kendari, 
Southeast Sulawesi 
117 198333CR Botanical Garden, 
Bogor, West Java 
20 194601 Cultural Park, Bali 118 198334CR Botanical Garden, 
Bogor, West Java 
21 195105 Cultural Park, Bali 119 198335CR Botanical Garden, 
Bogor, West Java 
22 195107 Cultural Park, Bali 120 198414CR Botanical Garden, 
Bogor, West Java 
23 1951016 Cultural Park, Bali 121 1-SO1 Mangrove, Jakarta 
24 180811CR Malang, East Java 122 2112-2 Mangrove, Jakarta 




26 180813CR Malang, East Java 124 2113SO Mangrove, Jakarta 
27 180814CR Malang, East Java 125 2114-1SO Mangrove, Jakarta 
28 1808210CR Malang, East Java 126 2115SO Mangrove, Jakarta 
29 180821CR Malang, East Java 127 2118-1 Mangrove, Jakarta 
30 180822CR Malang, East Java 128 2118-3 Mangrove, Jakarta 
31 180823CR Malang, East Java 129 2118SO Mangrove, Jakarta 
32 180824CR Malang, East Java 130 2120SO Mangrove, Jakarta 
33 180825CR Malang, East Java 131 2122-2 Mangrove, Jakarta 
34 180826CR Malang, East Java 132 2122-5 Mangrove, Jakarta 
35 180827CR Malang, East Java 133 2123-1BSO Mangrove, Jakarta 
36 180828CR Malang, East Java 134 2124-1SO Mangrove, Jakarta 
37 180829CR Malang, East Java 135 2125-2 (grey) Mangrove, Jakarta 
38 189921CR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
136 2125-2 (white) Mangrove, Jakarta 
39 189923ACR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
137 2125-3 Mangrove, Jakarta 
40 189923BCR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
138 2125-5 Mangrove, Jakarta 
41 190122BCR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
139 2126-1SO Mangrove, Jakarta 
42 190131ACR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
140 2126-2SO Mangrove, Jakarta 
43 190222CR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
141 2126-3SO Mangrove, Jakarta 
44 190224CR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
142 2126SO Mangrove, Jakarta 
45 190227CR Forest low altitude, 
Kendari, Southeast 
Sulawesi 
143 2126SO(3) Mangrove, Jakarta 
46 190711GyCR Cimahi, West Java 144 2126SO-1 Mangrove, Jakarta 
47 190712WCR Cimahi, West Java 145 2126SO-2 Mangrove, Jakarta 
48 190721CR Cimahi, West Java 146 2127SO Mangrove, Jakarta 
49 194813CR Cultural Park, Bali 147 2-1MKBSO Mangrove, West 
Kalimantan 
50 194821CR Cultural Park, Bali 148 2-2MKBSO Mangrove, West 
Kalimantan 
51 194822CR Cultural Park, Bali 149 3-BBSO Beach, Bali 
52 194823CR Cultural Park, Bali 150 4-1BKBSO Beach, West Kalimantan 
53 194831CR Cultural Park, Bali 151 4-2BKBSO Beach, West Kalimantan 
54 194912CR Cultural Park, Bali 152 4-3BKBSO Beach, West Kalimantan 
55 194921CR Cultural Park, Bali 153 4-4BKBSO Beach, West Kalimantan 
56 194931CR Cultural Park, Bali 154 4-5BKBSO Beach, West Kalimantan 
57 194933RCR Cultural Park, Bali 155 4-6BKBSO Beach, West Kalimantan 





59 194935CR Cultural Park, Bali 157 5-2BLSO Beach, Lampung 
60 194938CR Cultural Park, Bali 158 5-3BLSO Beach, Lampung 
61 195003R Cultural Park, Bali 159 6-2BPSO Beach, Papua 
62 195211CR Cultural Park, Bali 160 6BPSO Beach, Papua 
63 195213BCR Cultural Park, Bali 161 7BPSO Beach, Papua 
64 195213CR Cultural Park, Bali 162 9BLSSO Beach, Lampung 
65 195215CR Cultural Park, Bali 163 BLH 12-3 Bitung, North Sulawesi 
66 195217CR Cultural Park, Bali 164 C190221 Forest low altitude, 
Kendari, Southeast 
Sulawesi  
67 195218CR Cultural Park, Bali 165 C194911 Cultural Park, Bali 
68 195219CR Cultural Park, Bali 166 C194922A Cultural Park, Bali 
69 1952211CR Cultural Park, Bali 167 C1950A Cultural Park, Bali 
70 1952212CR Cultural Park, Bali 168 C195212 Cultural Park, Bali 
71 1952213CR Cultural Park, Bali 169 C195311 Cultural Park, Bali 
72 195222CR Cultural Park, Bali 170 C195321A Cultural Park, Bali 
73 195224CR Cultural Park, Bali 171 C196921 Botanical Garden, Bali 
74 195226CR Cultural Park, Bali 172 CA1-BKBSO Beach, West Kalimantan 
75 195227CR Cultural Park, Bali 173 CA2-SO12 Mangrove, Jakarta 
76 195227GnCR Cultural Park, Bali 174 DHE 2-1 Enggano Island, 
Bengkulu 
77 195228CR Cultural Park, Bali 175 DHE 9-4 Enggano Island, 
Bengkulu 
78 195231CR Cultural Park, Bali 176 GBSL-9 Lampung, Indonesia 
79 195232CR Cultural Park, Bali 177 GKRL-2 Lampung, Indonesia 
80 195233CR Cultural Park, Bali 178 GKRL-3 Lampung, Indonesia 
81 195321BCR Cultural Park, Bali 179 GKRL-4 Lampung, Indonesia 
82 195331CR Cultural Park, Bali 180 MAE  1-11 Enggano Island, 
Bengkulu 
83 195332CR Cultural Park, Bali 181 MAE 1-3 Enggano Island, 
Bengkulu 
84 195333CR Cultural Park, Bali 182 SHP 1-2 Enggano Island, 
Bengkulu 
85 195334CR Cultural Park, Bali 183 SHP 1-4 Enggano Island, 
Bengkulu 
86 195335CR Cultural Park, Bali 184 SHP 1-5 Enggano Island, 
Bengkulu 
87 195336CR Cultural Park, Bali 185 SHP 1-6 Enggano Island, 
Bengkulu 
88 195337CR Cultural Park, Bali 186 SHP 2-2 Enggano Island, 
Bengkulu 
89 195338CR Cultural Park, Bali 187 SHP 2-4 Enggano Island, 
Bengkulu 
90 195339CR Cultural Park, Bali 188 SHP 2-5 Enggano Island, 
Bengkulu 
91 1965114CR Botanical Garden, 
Bali 
189 SHP 6-2 Enggano Island, 
Bengkulu 
92 196511CR Botanical Garden, 
Bali 
190 SHP 6-3 Enggano Island, 
Bengkulu 
93 196512CR Botanical Garden, 
Bali 





94 196522CR Botanical Garden, 
Bali 
192 SHP 6-5 Enggano Island, 
Bengkulu 
95 196523CR Botanical Garden, 
Bali 
193 SHP 6-6 Enggano Island, 
Bengkulu 
96 196524CR Botanical Garden, 
Bali 
194 SHP 7-1 Enggano Island, 
Bengkulu 
97 196526CR Botanical Garden, 
Bali 
195 SHP 7-3 Enggano Island, 
Bengkulu 
98 196532CR Botanical Garden, 
Bali 
196 SHP 7-5 Enggano Island, 
Bengkulu 
 
Table S 2. List of isolated Actinobacteria with the closest species based on 16S rRNA 
gene analysis 
No. Name of Strain 
 
Closest type strain by 16S 




the sequence (%) 
 Streptomyces strain    
1 9BLSSO Streptomyces lanatus 97.03 99.9 
2 195105 Streptomyces cyaneus  98.77 50.7 
3 195107 Streptomyces cyaneus  98.77 50.6 
4 195227GnCR Streptomyces filipinensis   98.81 58.0 
5 DHE 9-4 Streptomyces spongiae  98.83 100 
6 190122BCR Streptomyces roietensis  98.89 58.2 
7 190233 Streptomyces glomeratus  98.96 33.3 
8 SHP 1-2 Streptomyces 
viridochromogenes 
99.03 99.9 
9 198414CR Streptomyces cinnabarigriseus 99.14 64.5 
10 GKRL-2 Streptomyces jiujiangensis 99.17 100 
11 198333CR Streptomyces 
griseochromogenes  
99.37 55.1 
12 C194911 Streptomyces spiralis  99.40 58.2 
13 SHP 6-4 Streptomyces xylanilyticus 99.45 100 
14 194601 Streptomyces viridiviolaceus  99.45 50.1 
15 GBSL-9 Streptomyces jiujiangensis 99.48 66.3 
16 1965114CR Streptomyces pharetrae 99.49 54.5 
17 195337CR Streptomyces cadmiisoli 99.51 56.3 
18 196932CR Streptomyces canus 99.52 58.0 
19 190234 Streptomyces misionensis  99.52 28.7 
20 197019CR Streptomyces antibioticus  99.55 61.7 
21 190235 Streptomyces rhizosphaericus  99.61 53.6 
22 C194922A Streptomyces prasinosporus  99.63 36.9 
23 C195311 Streptomyces olivaceus  99.71 47.5 
24 190224CR Streptomyces lannensis  99.72 48.7 
25 195003R Streptomyces tuirus  99.75 55.9 
26 198332CR Streptomyces gilvifuscus  99.75 55.1 
27 198335CR Streptomyces panaciradicis 99.82 38.5 
28 1951016 Streptomyces xiangtanensis 99.86 50.6 





30 195213BCR Streptomyces indiaensis  99.88 58.2 
31 GKRL-3 Streptomyces hyaluromycini  99.88 56.0 
32 GKRL-4 Streptomyces hyaluromycini  99.89 64.0 
33 4433 Streptomyces albogriseolus  100 58.6 
34 190221 Streptomyces lannensis  100 48.7 
35 190224 Streptomyces katrae  100 29.0 
36 190225 Streptomyces lucensis 100 30.3 
37 190231 Streptomyces lannensis  100 29.3 
38 180822CR Streptomyces 
griseorubiginosus  
100 61.1 
39 194813CR Streptomyces levis  100 58.2 
40 194823CR Streptomyces levis  100 46.6 
41 196511CR Streptomyces 
griseorubiginosus  
100 55.1 
42 196512CR Streptomyces antibioticus  100 58.8 
43 2122-5 Streptomyces badius 100 52.3 
44 C195321A Streptomyces levis  100 54.9 
45 C196921 Streptomyces violaceolatus  100 61.7 
46 MAE 1-3 Streptomyces albogriseolus  100 52.9 
47 SHP 1-4 Streptomyces hydrogenans  100 61.8 
48 SHP 1-5 Streptomyces hydrogenans 100 48.7 
49 SHP 1-6 Streptomyces hydrogenans  100 59.4 
50 SHP 2-2 Streptomyces hydrogenans  100 29.9 
51 SHP 2-4 Streptomyces hydrogenans  100 61.8 
52 SHP 2-5 Streptomyces olivaceus 100 45.1 
53 SHP 6-2 Streptomyces hydrogenans  100 57.8 
54 SHP 6-3 Streptomyces althioticus 100 42.5 
55 SHP 6-5 Streptomyces hydrogenans  100 61.8 
56 SHP 6-6 Streptomyces hydrogenans  100 53.5 
57 SHP 7-1 Streptomyces albidoflavus  100 68 
58 SHP 7-3 Streptomyces olivaceus 100 42.2 
59 SHP 7-5 Streptomyces hydrogenans  100 48.7 
 Non-Streptomyces 
strain 
   
1 195336CR Mycobacterium palauense 98.47 100 
2 194938CR Kibdelosporangium 
banguiense  
98.74 100 
3 196526CR Amycolatopsis thermalba  98.85 100 
4 2118-1 Nocardia rhizosphaerae 99.13 40 
5 195334CR Amycolatopsis magusensis  99.37 100 
6 190401 Microbispora hainanensis  99.38 44.7 
7 195232CR Couchioplanes caeruleus 
subsp. Caeruleus  
99.62 55.2 
8 4431 Nocardiopsis lucentensis  99.78 62.2 
9 4422 Nocardiopsis lucentensis  99.83 39.4 
10 180824CR Amycolatopsis japonica  99.80 35.5 
11 4421 Nocardiopsis lucentensis 99.86 49.3 




13 4435 Nocardiopsis lucentensis 99.87 54.0 
14 1982-4 Nocardia araoensis 99.87 52.7 
15 1982-1 Nocardia araoensis 99.87 52.5 
16 180813CR Nonomuraea endophytica  99.89 61.5 
17 MAE  1-11 Kitasatospora albolonga  99.93 100 
18 1808210CR Nonomuraea endophytica  100 58.9 
19 5931 Pseudonocardia kongjuensis  100 63.6 
20 1982-3 Micromonospora 
wenchangensis 
100 59.8 
21 4-5BKBSO Pseudonocardia 
carboxydivorans  
100 62.2 
22 BLH 12-3 Micromonospora aurantiaca  100 29.9 
23 C190221 Kitasatospora putterlickiae 100 46.6 
24 C1950A Saccharothrix xinjiangensis 100 29.2 
25 DHE 2-1 Kitasatospora albolonga  100 59.0 
 
Table S 3. List of strains that can produce extracts with moderate and strong activity 
against some microbes 





5294 Gram-negative bacteria 
Escherichia coli (moderate)  
Escherichia coli TolC (moderate) 
Chromobacterium violaceum (strong) 
Gram-positive bacteria  
Bacillus subtilis (strong) 
Staphylococcus aureus (strong) 
Micrococcus luteus (strong) 
  
Fungi 
Mucor hiemalis (strong) 
Pichia anomala (strong) 
Candida albicans (strong) 
2 195003R 
(Streptomyces sp.) 
5294 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Chromobacterium violaceum (moderate) 
Gram-positive bacteria  
Bacillus subtilis (strong) 
Staphylococcus aureus (strong)  
Micrococcus luteus (strong)  
Mycobacterium smegmatis (strong)  
Fungi 
Mucor hiemalis (moderate) 
3 1951016 
(Streptomyces sp.) 
5294 Gram-negative bacteria  
Escherichia coli TolC (moderate) 
Gram-positive bacteria  








Candida albicans (moderate) 
4 196512CR 
(Streptomyces sp.) 
5254 Gram-negative bacteria 
Chromobacterium violaceum (moderate) 
Gram-positive bacteria  
Bacillus subtilis (strong) 
Staphylococcus aureus (strong) 




Mucor hiemalis (moderate) 
Pichia anomala (moderate) 
5 C196921 
(Streptomyces sp.) 
5254 Gram-negative bacteria 
Escherichia coli TolC (moderate)  
Gram-positive bacteria  
Bacillus subtilis (moderate)  
Staphylococcus aureus (moderate)  
Fungi 
Candida albicans (moderate)  
6 4421  
(Nocardiopsis sp.) 
5254+SW Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria 
Staphylococcus aureus (moderate) 
Mycobacterium smegmatis (moderate) 
Bacillus subtilis (strong)  






Escherichia coli TolC (moderate) 
Gram-positive bacteria 
Staphylococcus aureus (moderate) 
Mycobacterium smegmatis (moderate) 
Bacillus subtilis (strong)  
Micrococcus luteus (strong) 
8 4431 
(Nocardiopsis sp.) 
5254 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria 
Micrococcus luteus (moderate)  
9 180822CR 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (strong) 
Staphylococcus aureus (strong)  
10 195232CR 
(Couchioplanes sp.) 
5294 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria  








5254 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria  
Staphylococcus aureus (moderate) 
12 C195212 5254 Gram-negative bacteria 
Escherichia coli TolC (moderate)  
Chromobacterium violaceum (moderate)
  
Gram-positive bacteria  
Bacillus subtilis (strong) 
Micrococcus luteus (moderate)  
13 SHP 6-3 
(Streptomyces sp.) 
5294 Gram-negative bacteria 
Escherichia coli TolC (moderate) 
Gram-positive bacteria  
Micrococcus luteus (moderate)  
14 190224 
(Streptomyces sp.) 
5254 Gram-positive bacteria 
Micrococcus luteus (moderate)  
Fungi 
Mucor hiemalis (moderate)  
Pichia anomala (moderate)  
15 190235 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Staphylococcus aureus (strong) 
Bacillus subtilis (strong) 
Micrococcus luteus (strong)  
Fungi 
Mucor hiemalis (strong) 
Pichia anomala (strong) 
Candida albicans (strong) 
16 195105 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Bacillus subtilis (strong) 
Staphylococcus aureus (moderate) 
Micrococcus luteus (moderate) 
Mycobacterium smegmatis (moderate) 
Fungi 
Mucor hiemalis (moderate) 
17 195107 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Bacillus subtilis (strong) 
Staphylococcus aureus (strong) 
Micrococcus luteus (moderate) 
Mycobacterium smegmatis (moderate) 
Fungi 
Mucor hiemalis (moderate) 
18 195334CR 
(Amycolatopsis sp.) 
5294 Gram-positive bacteria  








Mucor hiemalis (moderate) 
19 195337CR 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Staphylococcus aureus (strong) 
Fungi 
Mucor hiemalis (moderate) 
20 196526CR 
(Amycolatopsis sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Staphylococcus aureus (moderate)  
Fungi 
Mucor hiemalis (moderate) 
Candida albicans (moderate) 
21 197019CR 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Staphylococcus aureus (moderate) 
Fungi 
Mucor hiemalis (strong) 
22 C194922A 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Micrococcus luteus (moderate)  
Fungi 
Mucor hiemalis (moderate) 
23 C1950A 
(Saccharothrix sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Staphylococcus aureus (moderate) 
Micrococcus luteus (moderate) 
  
Fungi 
Mucor hiemalis (moderate) 
24 9BLSSO 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Staphylococcus aureus (moderate) 
Fungi 
Mucor hiemalis (moderate) 
25 SHP 1-4 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (moderate)  
Fungi 
Pichia anomala (moderate) 
26 SHP 6-6 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Fungi 
Pichia anomala (moderate) 
27 4422 
(Nocardiopsis sp.) 
5294+SW Gram-positive bacteria 
Staphylococcus aureus (moderate) 
Bacillus subtilis (strong)  
Micrococcus luteus (strong) 
28 SHP 1-2 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (strong) 




Micrococcus luteus (strong)  
29 4435 
(Nocardiopsis sp.) 
5294+SW Gram-positive bacteria 
Micrococcus luteus (moderate)  
Bacillus subtilis (strong)  
30 190231 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Bacillus subtilis (moderate) 
Micrococcus luteus (moderate) 
31 190234 
(Streptomyces sp.) 
5294 Gram-positive bacteria 
Micrococcus luteus (moderate) 
32 180824CR 
(Amycolatopsis sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (moderate) 
33 194823CR 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Staphylococcus aureus (moderate) 
34 194921CR 5294 Gram-positive bacteria 
Staphylococcus aureus (strong) 
35 195211CR 5294 Gram-positive bacteria  
Staphylococcus aureus (strong)  
36 195213BCR 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Staphylococcus aureus (moderate) 
37 195231CR 5294 Gram-positive bacteria  
Staphylococcus aureus (moderate) 
38 198335CR 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (strong) 
39 SHP 2-5 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (strong)  
Micrococcus luteus (strong) 
  
40 SHP 6-4 
(Streptomyces sp.) 
5294 Gram-positive bacteria  
Bacillus subtilis (moderate) 
Staphylococcus aureus (moderate) 
41 SHP 7-3 
(Streptomyces sp.) 
5254 Gram-positive bacteria  
Bacillus subtilis (strong)  













Mucor hiemalis (moderate) 




















Mucor hiemalis (strong) 








Pichia anomala (moderate) 




Mucor hiemalis (moderate)  
Pichia anomala (moderate)  
52 DHE 2-1 
(Kitasatospora sp.) 
5254 Fungi 
Mucor hiemalis (strong) 
Pichia anomala (moderate)  
53 SHP 1-6 
(Streptomyces sp.) 
5254 Fungi 
Pichia anomala (moderate) 
54 SHP 2-2 
(Streptomyces sp.) 
5254 Fungi 
Pichia anomala (moderate) 
55 SHP 2-4 
(Streptomyces sp.) 
5254 Fungi 
Pichia anomala (moderate) 
56 SHP 6-5 
(Streptomyces sp.) 
5254 Fungi 
Mucor hiemalis (moderate) 
Pichia anomala (moderate) 
57 SHP 7-1 
(Streptomyces sp.) 
5254 Fungi 
Mucor hiemalis (moderate) 
58 SHP 7-5 
(Streptomyces sp.) 
5254 Fungi 
Mucor hiemalis (moderate) 
Pichia anomala (moderate) 
 
 
Table S 4. List of nontoxic extracts having antiviral activity with moderate and strong 
level against HCV 
No. Strain Extract Antiviral activity 
level 
1 DHE 2-1 DHE 2-1_5254 Very Strong 
2 DHE 2-1 DHE 2-1_5294 Very Strong 
3 MAE 1-11 MAE 1-11_5294 Very Strong 
4 MAE 1-11 MAE 1-11_SYP Very Strong 
5 SHP 1-4 SHP 1-4_5294 Very Strong 
6 SHP 2-2 SHP 2-2_5294 Very Strong 
7 SHP 6-6 SHP 6-6_5294 Very Strong 
8 190231 190231_5294 Very Strong 
9 C190221 C190221_5254 Very Strong 




11 C195321A C195321A_5254 Very Strong 
12 C195321A C195321A_5294 Very Strong 
13 C196921 C19692 _5254 Very Strong 
14 4421 4421_5254 Strong 
15 4421 4421_5254+SW Strong 
16 4423 4423_5254 Strong 
17 4423 4423_5254+SW Strong 
18 4435 4435_5254+SW Strong 
19 5931 5931_5254+SW Strong 
20 5931 5931_5294+SW Strong 
21 SHP 1-5 SHP 1-5_5294 Strong 
22 SHP 1-6 SHP 1-6_5294 Strong 
23 SHP 6-2 SHP 6-2_5254 Strong 
24 SHP 6-2 SHP 6-2_5294 Strong 
25 SHP 7-5 SHP 7-5_5294 Strong 
26 190401 190401_5254 Strong 
27 C194911 C194911_5254 Strong 
28 C194922A C194922A _5254 Strong 
29 4422 4422_5254 Moderate 
30 4422 4422_5254+SW Moderate 
31 4423 4423_5294 Moderate 
32 4431 4431_5254 Moderate 
33 4431 4431_5294 Moderate 
34 4431 4431_5254+SW Moderate 
35 4433 4433_5254+SW Moderate 
36 4435 4435_5294+SW Moderate 
37 5931 5931_5254 Moderate 
38 BLH 12-3 BLH 12-3_5254 Moderate 
39 BLH 12-3 BLH 12-3_5294 Moderate 
40 DHE 9-4  DHE 9-4_5254 Moderate 
41 DHE 9-4 DHE 9-4_5294 Moderate 
42 SHP 1-6 SHP 1-6_5254 Moderate 
43 SHP 6-5 SHP 6-5_5294 Moderate 
44 C195311 C195311_5254 Moderate 
45 C196921 C196921_5294 Moderate 










Table S 5. Phenotypic comparison between Streptomyces sp. SHP 1-2, Streptomyces 
fumigatiscleroticus DSM 43154 T, Streptomyces malachitofuscus DSM 40332T, 
Streptomyces viridochromogenes DSM 40110 T, and Streptomyces misionensis DSM 
40306.  
Characteristic 1 2 3 4 5 
ISP 2 - growth Good Good  Good Good Sparse 






ISP 2 - aerial mycelium Traffic grey B, 
signal white 
Sparse Grey Blue 
grey 
None 
ISP 2 - soluble pigment None None None None None 
ISP 3 - growth Good Good  Good Good Good 
ISP 3 - colony color Ivory Yellow/
Brown 
Yellow Green Beige 
grey 
ISP 3 - aerial mycelium Telegrey 2, 
signal white 




ISP 3 - soluble pigment None None None Green None 
ISP 4 - growth Moderate Good  Good Good Sparse 
ISP 4 - colony color Ivory Colorless Colorless Green Olive 
brown 







ISP 4 - soluble pigment None None None None None 
ISP 5 - growth Good Good  Good Good Good 




Yellow Green Beige 
grey 
ISP 5 - aerial mycelium Telegrey 2, 
signal white 




ISP 5 - soluble pigment None None None Brown None 
ISP 6 - growth Good Good  Good Good Sparse 
ISP 6 - colony color Maize yellow Colorless Brown Green Beige 
grey 
ISP 6 - aerial mycelium Signal white None None Blue 
grey 
None 
ISP 6 - soluble pigment None None Brown Brown None 
ISP 7 - growth Good Good  Good Good Sparse 




Black Green Beige 
grey 
ISP 7 - aerial mycelium Traffic grey A, 
signal white 




ISP 7 - soluble pigment None Red Black None None 
Use of carbohydrate      
Glucose + - + + + 
Arabinose - + + + (+) 
Sucrose - - + - - 
Xylose - - - + ++ 
Inositol - - + + (+) 
Mannitol - + (+) + (+) 
Fructose - + + + (+) 




Raffinose - + - - - 
Cellulose - - - - - 
API ZYM      
Phosphatase alcaline ++ ++ ++ ++ ++ 
Esterase (C4) (+) + (+) + + 
Esterase Lipase (C8) (+) (+) (+) + ++ 
Lipase (C14) (+) - - - (+) 
Leucin arylamidase ++ ++ ++ ++ ++ 
Valine arylamidase (+) ++ + + ++ 
Cystine arylamidase (+) + + + + 
Trypsin - (+) + + - 
Chymotrypsin - (+) + (+) (+) 
Phosphatase acid (+) ++ ++ ++ ++ 
Naphtol-AS-BI-phosphohydrolase (+) ++ ++ ++ ++ 
α-Galactosidase - (+) - - + 
β-Galactosidase (+) ++ + ++ ++ 
β-Glucuronidase - - - - - 
α-Glucosidase ++ + ++ - ++ 
β-Glucosidase (+) ++ (+) ++ - 
N-acetyl-beta-glucoseamidase ++ - + ++ ++ 
α-Mannosidase - ++ ++ ++ ++ 
α-Fucosidase - - - - - 
API Coryne      
Nitrate reduction - + - - - 
Pyraziamidase - - - - - 
Pyrrolidonyl arylamidase - - - - + 
Alkaline phosphatase + + + + + 
β-Glucuronidase - - - - - 
β-Galactosidase - + - - + 
α-Glucosidase + + + - + 
N-acetyl -beta glucoseamidase + + - + + 
Esculin (beta glucosidase) + + - - + 
Urease - - - - - 
Gelatine(hydrolysis) + + + - + 
Glucose fermentation - - - - - 
Ribose fermentation - - - - - 
Xylose fermentation - - - - - 
Mannitol fermentation - - - - - 
Maltose fermentation - - - - - 
Lactose fermentation - - - - - 
Sucrose fermentation - - - - - 
Glycogen fermentation - - - - - 
++ more positive result; + positive result; - negative result; (+) weakly positive result; 1: Strain SHP 1-
2; 2: Streptomyces fumigatiscleroticus DSM 43154 T; 3: Streptomyces malachitofuscus DSM 40332; 

























Table S 6. NMR data of indolactam variant 1  
No No. 
Atom 
C Shift XHn H Shift H Multiplicity COSY N/ROESY H to C HMBC C to H HMBC TOCSY H Mark 
1 19 16.852 CH3 0.965 d (6.45) 2.57 2.57, 2.99, 3.47, 
4.68 
2.57, 2.99, 3.47, 
4.68 
37.25, 64.70, 68.56 2.57, 2.99, 
3.47, 4.68 
 
2 20 33.947 CH3 2.897 s 
 
2.57, 2.99, 3.47, 
4.15, 6.49 
4.68 68.56, 106.58, 
148.43 
  
3 10 35.514 CH2 3.082 dd (17.21, 
3.76) 
 
3.47, 3.67, 4.68, 
7.03 
3.47, 7.03 65.76, 119.71 7.03 '' 
4 10 35.514 CH2 3.107 m 7.03 3.67, 4.15, 4.68, 
6.35, 7.03 
3.47, 7.03 57.11 3.47, 7.03 ' 






0.96, 2.90, 2.99, 
3.47, 3.47, 4.68 











2.90, 3.11, 3.47, 






7 18 64.701 CH2 3.470 dd (10.54, 
3.00) 
2.99 0.96, 2.57, 2.90, 
6.49 
0.96, 4.68 16.85, 68.56 0.96, 2.57, 
4.68 
'' 
8 18 64.701 CH2 2.987 dd (10.54, 
4.20) 
2.57, 3.47 0.96, 2.57, 2.90, 
3.47, 4.68, 6.49 
0.96, 4.68 16.85 0.96, 2.57, 
4.68 
' 
9 16 65.758 CH2 3.475 dd (11.00, 
9.00) 
3.67, 4.15 2.57, 2.99, 3.08, 
3.67, 4.15, 4.68, 
6.35 




10 16 65.758 CH2 3.666 dd (11.00, 
4.41) 







11 14 68.556 CH 4.682 d (10.11) 2.57 0.96, 2.57, 2.99, 
3.08, 3.11, 3.47, 
4.15 








12 8 106.061 CH 6.934 d (8.00) 
 
10.05 6.49, 106.58 106.58, 119.71 6.49 
 






14 3 115.314 C 
    
3.09, 6.49, 7.03 




15 4 119.715 C 
    
3.08, 6.49, 6.93, 
6.97, 7.03 




        





18 9 141.131 C 
    
6.97 
   
19 5 148.435 C 
    
2.90, 4.68, 6.97 
   
20 13 172.953 C 
    
2.57, 4.68 
   
21 
   
3.093 m 4.15 
  





NH 6.353 br s 
 






















Table S 7.  NMR data of indolactam variant 2  
No Atom No. C Shift XHn H Shift H Multiplicity COSY N/ROESY H to C HMBC C to H HMBC TOCSY H Mark 
1 19 15.570 CH3 0.676 d (7.10) 2.58 2.58, 2.88, 3.44, 
3.58, 4.92, 6.44 







2 20 33.720 CH3 2.879 s 
 
0.68, 2.58, 4.15, 
4.92, 6.44 
4.92 67.20, 106.68, 
149.15 
  




3.01, 3.66, 4.15, 
4.92, 7.00 






4 10 35.072 CH2 3.013 dd (17.21, 
3.76) 
3.20, 4.15 3.20, 3.47, 3.66, 
4.15, 7.00 













0.68, 2.88, 3.44, 
3.58, 4.15, 4.92 

















2.58, 2.88, 3.01, 
3.20, 3.47, 3.66, 
4.92, 6.37 
3.01, 3.20, 3.47 65.73, 115.68 3.01, 3.20, 
3.47, 3.66 
 
7 16 65.732 CH2 3.661 dd (11.19, 
4.52) 
3.47, 4.15 3.01, 3.20, 3.47, 
3.58, 4.15, 6.37 
3.01, 3.20, 3.38, 
4.15 
35.07 3.01, 3.20, 
3.47, 4.15 
 
8 16 65.732 CH2 3.467 dd (11.00, 
9.25) 
3.66, 4.15 3.01, 3.58, 3.66, 
4.15, 6.37 
3.01, 3.20, 3.38, 
4.15 
35.07, 57.20 3.01, 3.20, 
3.66, 4.15 
 
9 18 66.469 CH2 3.581 dd (10.54, 
3.66) 
2.58, 3.44 0.68, 2.58, 3.44, 
3.47, 3.66, 4.92 
4.92 15.57, 37.45 0.68, 2.58, 
3.44, 4.92 
 
10 18 66.469 CH2 3.442 dd (10.54, 
3.23) 
2.58, 3.58 0.68, 2.58, 3.58, 
4.92 
4.92 15.57, 37.45, 67.20 0.68, 2.58, 
3.58, 4.92 
 
11 14 67.205 CH 4.919 d (10.40) 2.58 0.68, 2.58, 2.88, 
3.20, 3.44, 3.58, 
4.15 








12 8 105.567 CH 6.897 dt (8.00, 0.80, 
0.80) 
 









14 3 115.678 C 
    
3.01, 3.20, 4.15, 
6.44, 7.00 
   
15 4 119.620 C 
    
3.01, 6.44, 6.90, 
7.00 
   









18 9 141.235 C 
    
6.95, 7.00 
   
19 5 149.154 C 
    
2.88, 4.92, 6.44, 
6.90, 6.95 
   
20 13 173.958 C 
    
0.68, 2.58, 4.92 
   
21 1 
 
NH 9.981 br s 
 
6.90, 7.00 
    
24 12 
 
NH 6.369 br s 
 
3.47, 3.66, 4.15 







Table S 8. NMR data of nitrososaxin C 
Nitrososaxin Ca (CDCl3) 6526-61-63 (CDCl3) 
1H-NMR 13C-NMR 1H-NMR 13C-NMR 
0.86 (6H, d, 6.85 Hz) 22.63 0.87 (6H, d, 6.45) 22.64 
1.13-1.32 (18H, m) 26.12 1.14-1.27 (18H, m) 27.10 
1.51 (1H, m) 26.59 1.52 (1H, dt, 13.28 Hz, 6.59 Hz) 27.11 
1.94 (2H, q, 7.26 Hz) 27.38 1.71-1.81 (2H, br, s) 27.41 
4.13 (2H, t, 7.26 Hz) 27.95  27.96 
11.52 (1H, s) 28.81  29.11 
 29.27  29.29 
 29.45  29.46 
 29.55  29.57 
 29.64  29.64 
 29.89  29.93 
 39.04  39.04 
 61.38  65.12b 
aNishio et al., 1993226; bdetermined in HSQC-DEPT 
 
 
